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The use of the CapQOL (capacity to report subjective quality of life 
inventory) with a chronic schizophrenia sample that reside on care facilities. 
 
Mr N. McGrath. 
Department of Clinical Psychology, University of Lincoln, United Kingdom  
(e-mail: noel.mcgrath@lpt.nhs.uk) 
 
Abstract 
 
The capacity to report subjective quality of life inventory (CapQOL) is a brief 
screening tool designed to evaluate ability to appraise subjective QOL, complete 
related QOL measures and assess cognitive impairment. The purpose of this study 
was to assess the CapQOL’s test-retest reliability, internal consistency and 
associations with cognitive impairments (memory and executive functioning) and 
negative symptoms in a sample of people with chronic schizophrenia that reside on 
care facilities. The CapQOL, cognitive and schizophrenia symptom assessments 
were administered to 23 participants (mean age = 43, s.d. = 9.7, male = 13). The 
CapQOL had good test-retest reliability (rs (21) = .868, p < .01) and internal 
consistency (α=.850). 43% of the chronic schizophrenia sample were identified by 
the CapQOL as having the ability to complete a subjective QOL measure (a 
significantly smaller percentage than a prior study with an early psychosis patient 
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sample).  The CapQOL demonstrated a poor agreement with the cognitive 
assessments (κ-<.40) and a non-significant correlation with negative symptom 
scores (p>0.05). The main limitation of the study was the sample size that may 
have affected the range of scores on the measures, the resulting associations with 
the CapQOL and the number of factors that could be assessed. Further validation 
studies of the CapQOL are indicated. 
 
Key Words: Cognitive Impairment, Decision making, Psychometrics, Psychosis, 
Quality of Life, Questionnaires, Schizophrenia 
 
Introduction 
 
Cantril [1] introduced a cognitive element to the conceptualisation of QOL when he 
proposed that overall life satisfaction could be assessed from the difference 
between a person’s aspirations and satisfactions [2]. He developed a self-
anchoring scale on which respondents could place themselves relative to their best 
or worst life circumstance that they could imagine [1]. Baker and Intagliata [3] 
developed a multidimensional conceptual model of QOL based on the relationships 
among individual experience, individual health status, external environments and 
quality of life responses. They operationalised QOL as both a global measure of 
well-being and an individual’s response to a variety of life domains. Awad [4] 
proposed a model of QOL in schizophrenia patients that viewed QOL as an 
interaction between three key determinants: the severity of psychotic symptoms, 
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side-effects including subjective responses to anti-psychotic medication and 
psychosocial performance (see appendix 1.1 for an extended  description of QOL 
models). 
 
QOL measures are abundant within the literature and are increasingly being 
developed and used as screening and outcome measures with schizophrenia 
patients. They are being designed to assess the diverse range of impairments and 
consequences that impact on an individual that has schizophrenia. Some of these 
measures focus on the objective circumstances of a person’s life, (e.g. their living 
situation), others emphasise the subjective experience of satisfaction with those 
circumstances and others focus on the person’s global satisfaction with life as a 
whole [5] (see appendix 1.2 for an extended discussion of objective and subjective 
determinants of QOL). In their review of QOL measures for people with 
schizophrenia, Prince and Gerber [5] acknowledged the usefulness of assessing 
objective circumstances of a person’s life, however, they believed that client-
elicited subjective QOL measures were the most appropriate method to assess 
and monitor changes in QOL. 
  
The credibility of self-reports on subjective QOL measures in select populations (ie. 
Dementia [6-7], Traumatic Brain Injury [8-9], Learning Disabilities [10]) (see 
appendix 1.3 for an extended discussion of the validity and reliability of QOL 
reports in select clinical populations) and especially people with schizophrenia has 
been questioned [11]. This is not the case in people affected by physical/medical 
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disorders. It seems that there was a wide spread belief that the self reports given 
by people with schizophrenia were unreliable. The credibility of their self reports 
had been raised in the context of history taking, treatment adherence and insight 
into their illness [12]. This belief appears to have changed, largely due to research 
that has evaluated the reliability and validity of self-rated QOL estimates in people 
with schizophrenia. Voruganti et al. [12] found that clinically compliant and stable 
schizophrenia patients could evaluate and report their QOL with a high degree of 
reliability and concurrent validity. They concluded that self-report QOL measures 
were useful tools in clinical trials and outcome studies with this population [12] (see 
appendix 1.4 for an extended discussion of the validity and reliability of the QOL 
reporting in schizophrenia). 
 
Andrews and Withey [13] proposed that the subjective experience of QOL includes 
both a cognitive and an affective element. The cognitive element focuses on the 
judgement or individual appraisal of the individuals’ degree of satisfaction and the 
affective element measures the degree of happiness or negative affect of the 
individual [13]. These elements may be less well developed in certain individuals 
and so they may lack the mental capacity to appraise and report their subjective 
QOL experience using a subjective QOL measure. Wong et al. [14] described the 
‘affective’ element of QOL as subjective (e.g., another person cannot tell an 
individual how happy they are about a situation and the appropriateness of how 
happy they should feel), however the ‘cognitive’ element which is the capacity to 
make judgements and appraise an individual’s level of satisfaction with their own 
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life, may be affected by impaired cognition, intellect or reasoning abilities [14]. 
These problems are more prevalent within certain clinical populations (e.g. people 
diagnosed with schizophrenia) [14]. Wong et al. [14] therefore developed a 
measure that claimed to assess these cognitive difficulties objectively (see 
appendix 1.5 for an extended discussion of the cognitive impairments associated 
with schizophrenia). 
 
Wong et al. [14] developed the CapQOL (capacity to report subjective quality of life 
inventory), a brief screening tool, designed for people with a wide range of mental 
disorders. It consists of 12 questions, which assess five areas that they identified 
as important in completing subjective QOL measures (see appendix 1.6 for an 
extended discussion of the QOL measures reviewed by Wong et al., [14]) (see 
appendix 1.7  for an extended discussion of the development and structure of the 
CapQOL) (see appendix 1.8 to view a copy of the CapQOL). Wong et al. [14] 
administered the CapQOL to 442 patients with early psychosis and found it to be 
reliable and internally consistent. They claimed that the CapQOL had face validity 
because it was developed according to literature that described the difficulties 
administering QOL measures, as well as the opinions of experienced professionals 
who measure QOL [14]. It would appear that the CapQOL also has content validity 
in that several of its items are depicted in actual QOL measures. Using the 
CapQOL, Wong et al. [14] found that 89% of their participants were assessed to be 
able to complete a subjective QOL measure. Wong et al. [14] suggested that the 
high percentage of participants assessed to have capacity may have been due to 
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their participant sample being young and in the early stages of a psychotic illness. 
This would make them less likely to be affected by cognitive impairments and 
negative symptoms (see appendix 1.9 for an extended discussion of negative 
symptoms in schizophrenia), which are more characteristic in chronic psychosis 
patients [14]. Their report suggested further and more extensive validation studies 
on the CapQOL with people with psychotic disorders (both early and chronic 
psychoses).   
 
The CapQOL has been shown to be a reliable and internally consistent instrument 
when used with an ‘early psychosis’ patient group. It was designed to evaluate the 
cognitive ability of respondents to appraise and judge their subjective QOL and 
capability to complete a subjective QOL measure. The CapQOL would therefore be 
administered before a subjective QOL measure so that respondents that do not 
have the cognitive ability and/or capability are identified [14]. 
 
The primary aim of this study was to assess the CapQOL’s reliability and internal 
consistency with a sample of people with schizophrenia that reside on care 
facilities. It had also been suggested that this population would be more affected by 
cognitive impairments and negative symptoms than the early psychosis sample 
from the Wong et al. [14] study.  The secondary aim was therefore to compare the 
impaired/unimpaired scores from this study with the Wong et al. [14] study, and to 
assess the associations between the CapQOL, cognitive impairments (memory 
and executive functioning) and negative schizophrenia symptoms. 
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The six experimental hypotheses were: 
1. The CapQOL will demonstrate reliable and internally consistent properties. 
2. There will be a significant difference between the chronic schizophrenia 
sample’s impaired/unimpaired global score on the CapQOL (from this study) 
and the early psychosis sample’s impaired/unimpaired global score on the 
CapQOL (from the Wong et al. [14] study). 
3. There will be a significant association between the impaired/unimpaired 
global score on the CapQOL and memory impairment. 
4. There will be a significant association between the impaired/unimpaired 
global score on the CapQOL and executive functioning impairment. 
5. There will be a significant association between the impaired/unimpaired 
global score on the CapQOL and both memory and executive functioning 
impairment (a ‘cognitive impairment’). 
6. There will be a significant association between global scores on the 
CapQOL and negative schizophrenia symptoms. 
 
Methods 
 
Participants 
 
Sixty-eight people were identified and asked to participate in the study from 7 care 
facilities in Lincolnshire. Six of the care facilities were psychiatric inpatient wards 
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and 1 of the care facilities was a residential home (for people with severe and 
enduring mental illness requiring 24 hour supported care). Forty-five of those 
people declined to take part in the study. Of the 23 participants, 6 were residents at 
the residential home. None of the participants dropped out of the study. Thirteen 
(56%) of the participants were male. The age range of the participants was 
between 25 and 64 years of age, with a mean age of 43 (s.d. = 9.7) and a mean 
pre-morbid IQ of 101 (s.d. = 14.2). The participants were selected on the basis of 
being admitted to the care facility and having received a diagnosis of schizophrenia 
(identified in their medical notes). Most of the participants had been through 
multiple psychotic episodes and their condition was described as ‘severe and 
enduring mental illness’. All of the participants were being treated with anti-
psychotic medication. There were no age restrictions, however participants were 
excluded if they did not understand or speak English or give consent.  
 
Measures 
 
Capacity to report subjective quality of life inventory (CAPQOL) [14] (see 
appendix 1.8 to view a copy of the CapQOL): the CAPQOL is a 12 item interview 
questionnaire that assesses an individuals cognitive ability to appraise and make 
judgements on their subjective QOL and their ability to complete a subjective QOL 
measure.  
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National Adult Reading Test 2nd Edition (NART) [15] : the NART is a published 
measure that has been standardised against the Weschler Adult Intelligence 
Scale-Revised (WAIS-R) to produce estimates of pre-morbid IQ. It consists of 50 
words presented in increasing difficulty. The errors produced by the participant on 
the NART were used to determine an estimate of their premorbid Full Scale IQ. 
 
The Adult Memory Information Processing Battery (AMIPB): Story Recall Test 
[16]: the AMIPB is a series of standardised memory tests. The story recall test was 
used to assess immediate registration of verbal information and retention over 
time. The test involved the participant being read a short story and then being 
asked to recall it immediately and after a 30-minute delay. The raw scores for 
immediate and delayed recall were converted to z-scores for analysis. 
 
The Hayling and Brixton Tests (H&B) [17]: these two tests assess executive 
functioning, that is the cognitive processes that are supported by frontal lobe 
structures. Raw scores were derived for each test and age and pre-morbid IQ cut-
off scores were used to enable the assessor to identify an executive functioning 
impairment. 
 
Positive and Negative Syndrome Scale (PANSS) [18]: the PANNS is a 
published, 30-item scale that measures the degree of positive and negative 
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symptoms of an individual. The seven positive symptom and seven negative 
symptom items were rated by the assessor using the PANNS formalised 
psychiatric interview and the PANNS informant questionnaire (completed by a 
member of the participants care team). 
 (see appendix 2.1 for an extended description and justification of the measures 
that were used) 
  
Procedure 
 
The clinical psychologist responsible for the care facilities approached the 
identified people to seek permission for the chief investigator to speak to them 
about the study. The clinical psychologist gave each identified person a copy of an 
information sheet that explained the study. If the person agreed to be seen, the 
chief investigator (test administrator) met with them, discussed the information 
sheet and answered any questions about the study. If the person gave verbal 
consent, they were asked to sign a consent form. In order to safeguard 
participants, a member of their nursing team was present to verify that the person 
had not been coerced into participating in the study and/or lacked the capacity to 
consent to participate in the study. The study was subject to full NHS ethical and 
research and design committees (see appendix 2.2 for the NHS Ethics and 
Research and Design committees’ approval letters).  
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A within subjects design was used with participants completing all of the measures. 
The order that the measures were presented to participants was randomised. 
There were two orders of presentation: 
1. CapQOL followed by the cognitive and PANNS assessments 
2. Cognitive and PANNS assessments followed by the CapQOL 
At the first meeting, all of the measures were administered. In order to assess test-
retest reliability, the CapQOL was re-administered 7-14 days later (see appendix 
2.3 for a rationale for the re-administration interval and sample size).  
 
Analysis 
 
The ‘cut-off’ (pass/fail) scores on the CapQOL were the same as those used in the 
Wong et al. [14] study.  Those individuals that received a global score of between 4 
and 5 on the CapQOL were identified as having the cognitive ability to appraise 
their subjective QOL and were assigned as ‘passing’ the CapQOL assessment.  
Those individuals that received a global score of between 1 and 3 on the CapQOL 
were identified as not having the cognitive ability to appraise their subjective QOL 
and were assigned as ‘failing’ the CapQOL assessment.   
 
The participant’s NART score was used to estimate pre-morbid IQ. In order to 
identify a ‘memory impairment’, the scores on the AMIPB: Story Recall assessment 
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and NART were converted to z-scores. If the z-score on the AMIPB: Story Recall 
was two z-scores below that of the NART, participants were classified as having a 
‘memory impairment’. In order to identify an ‘executive functioning impairment’ on 
the Hayling & Brixton (H&B) Tests, 5% level tables for age and IQ from the Hayling 
& Brixton (H&B) manual [17] were used. 
 
The statistical analyses were performed using the Statistical Package for Social 
Sciences: Version 14 (SPSS: 14). The test-retest reliability of the CapQOL was 
measured by Spearman correlations. The internal consistency of the CapQOL was 
derived from Cronbach’s alpha statistic. Chi-square analysis was used to compare 
the impaired/unimpaired scores on the CapQOL between this study and the Wong 
et al. [14] study. The associations between the global score and individual domain 
scores were measured by Spearman correlation analysis. Screening of the data for 
principal components analysis with varimax rotation were performed on the domain 
scores. Cohen’s Kappa statistic was used to detect associations between the 
AMIPB: Story Recall test and the pass/fail global score on the CapQOL and the 
Hayling and Brixton Tests and the pass/fail score on the CapQOL. Spearman 
Correlations were used to detect associations between PANNS symptom scores 
and global scores on the CapQOL.  
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Results 
 
At the first administration, 10 (43%) of the participants obtained a global score of 4 
or 5 on the CapQOL indicating that they were ‘unimpaired’ and had the ability to 
complete a subjective QOL measure. At the second administration, 13 (57%) of the 
participants obtained a global score of 4 or 5. There was a significant correlation 
between the global scores at the first and second administrations (rs (21) = .868, p 
< .01) indicating good test-retest reliability (see appendix 3.1 for data screening). 
There was a ‘good’ agreement [19] between impaired/unimpaired global scores at 
the first and second administrations (κ-.738) (see appendix 3.2 for an alternative 
analysis using the Bland & Altman (1995) method). There was a non significant 
effect for order of presentation of measures (p>0.05) (see appendix 3.3 for χ2 
analysis of order of presentation). The frequency distribution of the domain and 
global scores at time 1 and time 2 are presented in tables 1 and 2.  
 
Table 1. Distribution of domain scores on the CapQOL at time 1 and time 2 
 
 Number of 
participants (% 
of score) 
Domain Score Time 1 Time 2 
Acquiescence 0 5 (22) 6 (26) 
 1 18 (78) 17 (74) 
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 Number of participants 
(% of score) 
Consistency 0 4 (17) 2 (9) 
 1 19 (83) 21 (91) 
Understanding of the 5-point scale 0 3 (13) 2 (9) 
 1 2 (9) 3 (13) 
 2 18 (78) 18 (78) 
Understanding of domain: Economic status 0 5 (22) 4 (17) 
 1 6 (26) 7 (30) 
 2 12 (52) 12 (52) 
Understanding of domain: Relationship with others 0 7 (30) 4 (17) 
 1 6 (26) 8 (35) 
 2 10 (44) 11 (48) 
Awareness of situation and comparison: Economic  0 10 (43) 11 (48) 
Status 1 2 (9) 2 (9) 
 2 11 (48) 10 (43) 
Awareness of situation and comparison: Relationship  0 8 (35) 6 (26) 
with others 1 5 (22) 3 (13) 
 2 10 (43) 14 (61) 
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Table 2. Distribution of global scores on the CapQOL at time 1 and time 2 
 
 Number of participants (%) 
Global Score Time 1 Time 2 
1 4 (17.4)  2 (8.7) 
2 3 (13.0) 6 (26.1) 
3 6 (26.1) 2 (8.7) 
4 4 (17.4) 6 (26.1) 
5 6 (26.1) 7 (30.4) 
 
The internal consistency of the CapQOL of all the items including the global score 
was α=.850 (see appendix 3.4 for analysis of domain/item statistics). The 
associations between the global score and the domain scores are presented in 
table 3. The ‘acquiescence’ and ‘consistency’ domains showed a non-significant 
correlation (p>0.05) with the global score (see appendix 3.5 for an alternative 
analysis of these domains using χ2 statistics). The other domains showed 
significant correlations (p<0.05) with the global scores. The data was not suitable 
for principal components analysis (see appendix 3.6 for principal component 
analysis data screening) and so the factor structure of the domain scores of the 
CapQOL could not be identified. 
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Table 3. Spearman correlation between global scores and domain scores on the 
CapQOL 
 
Domain Spearman 
correlation 
Significance 
Value (p) 
Acquiescence 0.29 0.175 
Consistency 0.41 0.054 
Understanding of the 5-point scale 0.44  0.034 
Understanding of domain: Economic 
status 
0.62 < 0.001 
Understanding of domain: relationship 
with others 
0.87 < 0.001 
Awareness of own situation and 
comparison: Economic status 
0.84 < 0.001 
Awareness of own situation and 
comparison: Relationship with others 
0.71 < 0.001 
 
There was a significant difference on the impaired/unimpaired global scores 
between this study and the Wong et al. [14] study (χ2 (1) = 39.995, p < .001). The 
levels of agreement of the CapQOL and the cognitive assessments are presented 
in table 4. Twelve (52%) of the participants were categorised as having a ‘memory 
impairment’ on the AMIPB: Story Recall. The CapQOL demonstrated a ‘poor 
agreement’ [19] with memory impairment/unimpairment on the AMIPB: Story 
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Recall (κ-.128). Fourteen (61%) of the participants were categorised as having an 
‘executive functioning impairment’ on the Hayling Test. The CapQOL demonstrated 
a ‘poor agreement’ [19] with executive functioning impairment/unimpairment on the 
Hayling Test (κ-.052). Nine (39%) of the participants were categorised as having 
an ‘executive functioning impairment’ on the Brixton Test. The CapQOL 
demonstrated a ‘poor agreement’ [19] with executive functioning on the Brixton 
Test (κ-.298). Four (17%) of the participants were categorised as having both types 
of cognitive impairment (memory impairment and executive functioning).  The 
CapQOL demonstrated a ‘poor agreement’ [19] with those participant’s with both 
types of cognitive impairment (κ-.195). 
 
Table 4. Number of participants classified as impaired/unimpaired on the CapQOL 
and cognitive assessments 
 
  CapQOL 
  Impaired Unimpaired 
AMIPB Impaired 5 7 
 Unimpaired 6 5 
Hayling Test Impaired 7 7 
 Unimpaired 4 5 
Brixton Test Impaired 6 3 
 Unimpaired 5 9 
Both cognitive assessments Impaired 3 1 
 Unimpaired 8 11 
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PANNS data was only collected for 13 participants (10 participants either became 
too distressed during the PANNS interview or declined to take part in that section 
of the assessment due to the time that it took to complete (up to 60 minutes)). The 
mean PANNS negative score was 19 (s.d. = 6) and mean positive score was 16 
(s.d. = 8). There was a non significant correlation between global scores and 
PANNS negative scores (rs (11) = -.471, p = .104) and PANNS positive scores (rs 
(11) = -.307, p = .307). 
 
Discussion 
 
The CapQOL demonstrated good test-retest reliability and internal consistency with 
this sample of people with chronic schizophrenia. As predicted, this chronic 
schizophrenia sample had more difficulties completing the CapQOL than the early 
psychosis sample from the Wong et al. [14] study. Approximately 1 in 5 of the 
participants acquiesced, demonstrated inconsistent responses and lacked ability to 
understand the 5-point scale. Approximately half of the participants experienced 
difficulties in understanding, comparing and having an awareness of economic and 
relationship domains.  
 
This finding suggests that in order to obtain valid and reliable QOL reports in 
chronic schizophrenia populations, screening should take place using a measure 
such as the CapQOL. When responding difficulties are identified, the question 
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and/or response format of the QOL measurement tool would need to be modified 
accordingly. For example, those individuals that are identified as acquiescing could 
be further probed for meaning using scripts (see appendix 4.1 for a discussion of 
additional alterations to QOL measurement). The development of a schizophrenia 
specific QOL measure that does not contain modifiers, complex question 
structures, Likert Scales and abstract QOL domains would also be supported by 
this study’s findings (see appendix 4.2 for an extended discussion of condition 
specific vs. general QOL measurement).  
 
The cognitive testing results from this study were consistent with the literature that 
reported significant levels of memory and executive functioning impairments in 
people with schizophrenia, however, the CapQOL was not sensitive to those 
difficulties. The validity of the CapQOL as a measure of cognitive functioning is 
questionable given these findings. Additional, independent validation and 
investigation using other memory (see appendix 4.3 for an extended discussion of 
memory assessment) and executive functioning measures (see appendix 4.4 for 
an extended discussion of executive functioning assessment) would be 
recommended. It is possible that impaired memory and executive function do not 
affect ability to appraise and report subjective QOL. Perhaps other cognitive 
impairments associated with schizophrenia (e.g. attention and vigilance) affect this 
ability, and should be evaluated in future research (see appendix 4.5 for a 
discussion of attention and vigilance observations and implications for future 
research). 
 20 
 
The global scores on the CapQOL did not demonstrate statistically significant 
correlations with negative symptomatology and were based on a small (n = 13) 
participant sub-sample. It seems likely that a shorter, more acceptable measure of 
negative symptomatology would have led to an increased sub-sample and range of 
negative symptom scores. The correlation value of this study (r = -.471) was larger 
than the Wong et al. [14] study (with n = 442), suggesting that a larger sample size 
would have achieved statistical significance (see appendix 4.6 for an extended 
discussion of PANNS results and implications for future research).  
 
There are several limitations that need to be considered in relation to the findings. 
Firstly, the sample size (n = 23) was very small and a large number of the people 
that were identified and approached about the study declined to take part. It seems 
likely that some of those people that declined were more acutely psychotic than the 
participant sample. This reduced the possible range of scores on the measures 
and the resulting associations with the CapQOL. The small sample size also 
limited the number of factors that could be assessed, for example, residency (i.e. 
ward / residential-home) factors could not be evaluated (see appendix 4.7 for an 
extended discussion of recruitment difficulties and declining rates in other studies). 
Secondly, this study did not include a measure of QOL and so test-retest 
correlations of the CapQOL could not be compared with test-retest correlations of 
an actual QOL measure. Thirdly, there was no assessment of inter-rater reliability 
on the CapQOL and the assessor was not formally ‘trained’ in its use (see 
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appendix 4.8 for an extended discussion of inter-rater reliability). Fourthly, it would 
have been desirable for the PANNS and cognitive assessments to have been 
completed ‘blind’ to the CapQOL, however, due to limited resources the order of 
presentation was ‘randomised’. Finally, a limitation of the CapQOL is that it is not 
based on any theoretical model or process and so cannot be evaluated against 
them (see appendix 4.9 for an extended discussion of theoretical models) (see 
appendix 4.10 - 4.12 for additional limitations of the study). 
 
It is important to regularly screen capacity to report subjective QOL because 
inaccurate reporting of QOL can have significant adverse affects on a patient’s 
rehabilitation care programme. Regular screening should also be aimed at 
identifying those people whose impaired capacity is temporary and those people 
that need additional assistance in reporting their subjective QOL. At present, there 
is no evidence to support Wong et al. [14] claim that the CapQOL ‘objectively 
measures cognitive impairment’. Before the CapQOL is used in clinical settings, 
repeated independent validation in early psychosis and chronic schizophrenia 
populations should be conducted. Future studies could validate the CapQOL for 
other conditions such as mood disorders, learning disabilities, dementia or brain 
injury (see appendix 4.13 - 4.17 for remaining discussion points).  
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Appendix 1.1: Extended description of QOL models 
 
Figure 1 outlines the conceptual model of QOL as presented by Baker and 
Intagliata (1982). It summarises the differing areas of QOL that are researched.  
 
 
 
Figure 1. Baker and Intagliata’s (1982) conceptual model of QOL (reproduced from 
Baker & Intagliata, 1982) 
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Focus 1 is concerned with the objective environment and the counting of social 
indicators, e.g. physical, social, economic, political and cultural environmental 
aspects. Focus 2 is concerned with people’s perceptions of the physical 
environment. This focus recognises that people view the world differently. Focus 3 
is concerned with the actual state of health and well-being of a person. It covers 
their ‘internal states’, e.g. their needs, desires, knowledge, beliefs, values and 
attitudes. Focus 4 is concerned with the behavioural outcomes of a person’s 
interactions with their environment and how they cope with unpleasant 
environments. This focus assumes that people try to avoid painful life experiences 
and increase their skills to alter their environment. Focus 4 suggests that we find 
out about peoples perceived levels of QOL through their responding behaviour on 
QOL questionnaires and interviews (Baker & Intagliata, 1982). 
 
Awad (1992) developed a conceptual model of QOL that is specific for people with 
schizophrenia receiving antipsychotic drug treatment. The model proposes that the 
person’s perception of QOL is determined by an interaction between three key 
determinants: the severity of psychotic symptoms, side-effects including subjective 
responses to anti-psychotic drugs and the level of psychosocial performance 
(Awad, 1992).  Other influences dynamically influence the perception of QOL and 
include personality characteristics, pre-morbid adjustment, values and attitudes, 
resources and opportunities available (Awad, Vorunganti & Heslegrave, 1997).  
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Awad et al. (1997) assessed the validity of the Awad (1992) Multidimensional 
Model of QOL and found that severity of illness and subjective responses to anti 
psychotic drugs emerged as key determinants of QOL (Awad et al., 1997). They 
concluded that the key aspects of the model were endorsed. Limitations to this 
validation study included the population: predominantly symptomatic but stable 
psychotic patients. These patients would not be representative of the large 
spectrum of schizophrenic population (Awad et al., 1997). Criticisms of the model 
were its narrow focus (i.e. the impact of anti psychotic medications on the QOL of 
people with schizophrenia) and that it was not broad enough to assess social or 
vocational interventions (Awad et al., 1997). 
 
Lehman (1983) developed a hierarchical model of QOL using his quality of life 
interview (QLI) schedule with 278 people with severe and enduring mental illness. 
This model assumes that QOL is subjective and reflected in a “sense of global 
well-being” (Lehman, 1983). In common with Awad et al. (1997), Lehman’s (1983) 
model identified psychosocial factors (e.g. safety, unemployment, financial issues 
and family and social relations) as primary determinants of QOL (Lehman, 1983). 
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Appendix 1.2: Objective and subjective determinants of QOL 
 
Objective determinants of QOL 
 
Sullivan, Wells and Leake (1991) found that social relations and finances were the 
main determinants of QOL. Levitt, Hogan and Bucosky (1990) found that number 
of readmissions in the previous year, frequency of family contacts, satisfaction with 
social life, mental health and adult education were key determinants in their sample 
of people with severe and enduring mental illness.  
 
The most commonly used QOL measures use objective indicators (Lehman, 1983). 
Lehman (1983) felt that their popularity arose from their apparent objectivity, ease 
of use and the impression that they represent society’s values. He argued that 
there was an ‘implicit belief’ that objective QOL measures accurately reflected the 
values and beliefs of the people being studied (Lehman, 1983). The literature 
however, does not support this belief with objective life conditions only being 
marginally related to subjective experience (Andrews & Withey, 1976; Kennedy, 
Northcott & Kinzel, 1978; Najman & Levine, 1981). Lehman (1983) suggested that 
it is therefore important to ask people about how they feel about their lives. 
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Subjective determinants of QOL 
 
Subjective QOL questionnaires appear to measure several related constructs that 
include “life satisfaction”, “morale”, “happiness”, “positive wellbeing” and “mental 
health” (Lehman, 1983). It has been argued that even though these constructs are 
similar, they are not equivalent (Lehman, 1983). This raises the question about 
conceptual clarity and the comparability of measurement across studies (George, 
1979). An example to illustrate this difficulty could be “happiness”, defined as “the 
affect that people feel toward their current affairs” and “life satisfaction” defined as 
“a cognitive assessment of progress toward desired goals” (George, 1979). 
Empirical research has demonstrated that these two constructs differ, with the 
finding that reported life satisfaction increases with age and happiness decreases 
(Campbell, Converse & Rodgers, 1976). Lehman (1983) argued that clearer 
definitions and meanings of subjective QOL determinants are required and how 
they relate to mental health. 
 
Appendix 1.3: Validity and reliability of QOL reporting in select clinical  
populations 
 
Older adults with dementia 
 
The ability and point at which older adults with dementia can competently complete 
subjective QOL measures has been questioned (Lawton, 1994; Rabins, Kasper, 
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Kleinman, Black & Patrick, 1999). It had been assumed that people with dementia 
would not be able to rate their own QOL because of the characteristics of the 
condition (Logsdon, Gibbons, McCurry & Teri, 2002). The ability to understand the 
QOL questions and communicate subjective experiences had been thought to be 
influenced by the variety of associated impairments in memory, attention, 
judgement, insight and communication (Logsdon et al., 2002). The increased risk 
of agitation, depression and psychosis in this population were also thought to 
impact on the reliability and validity of the QOL response (Logsdon et al., 2002).  
 
Post (1994) had suggested that what is important for a persons QOL may change 
as the dementia progresses or the individuals living situation changes (Post, 1994). 
For example, what seems important in the early stages of the condition (e.g. 
retaining intellectual capacity) may be less important in the later stages (where 
comfort and safety are prioritised) (Post, 1994). It would seem that this observation 
has implications for the type of QOL questions that are used with dementia 
populations (e.g. retention of intellect vs. comfort and safety) and that the validity 
and reliability of the responses could be enhanced by considering the individuals 
‘stage’ of dementia and priorities, and tailoring the questions accordingly.  
 
Logsdon et al. (2002) used the Quality of Life-Alzheimer’s Disease (QOL-AD) 
Scale (Logsdon, Gibbons, McCurry & Teri, 1999) to evaluate the impact of 
cognitive impairment on the reliability and validity of the measure. They found that 
of the 177 participants that were interviewed, 155 were able to complete the QOL-
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AD (Logsdon et al., 1999). They reported that only 22 were unable to understand it 
sufficiently to provide meaningful responses (Logsdon et al., 2002). The main 
difference between those who could complete the QOL-AD (Logsdon et al., 1999) 
and those who could not were related to cognitive and functional status. The mean 
MMSE score for the participants who could not complete the measure was 4.1 (SD 
= 3.2, range 0-10) compared with 18.1 (SD= 5.9, range 4-29) who could complete 
the measure (F(1,175) = 120.2, p<.001) (Logsdon et al., 2002). This study 
concluded that it was possible for people with mild to moderate dementia to reliably 
and validly rate their own QOL (Logsdon et al., 2002) and that cognitive ability is an 
important determinant of ability to report QOL. This finding provides support for the 
development of a cognitive screening tool (e.g. the CapQOL), and a rationale for 
assessing associations with cognitive impairment in this study (see appendix 1.5 
for further descriptions of cognitive impairment in schizophrenia). 
 
Traumatic Brain Injury (TBI) 
 
A significant proportion of people with TBI have cognitive and physical impairments 
(DePalma, 2001). The length and type of QOL measurement used with this 
population has been affected by their ‘lack of concentration’ (DePalma, 2001). It 
has also been suggested that certain TBI patients are ‘emotionally labile’ and have 
difficulty with interactions that ask them to recall their traumatic incident or talk 
about their feelings (DePalma, Fedorka & Simko, 2003). Another problem with 
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measures of QOL in TBI are that some of this population may not be able to recall 
their lives and QOL prior to the trauma (DePalma et al., 2001).  
 
DePalma et al. (2003) studied the QOL experienced by severe TBI survivors. They 
used the Sickness Impact Profile (SIP) where many patients commented on the 
length of time and mental fatigue that they experienced. DePalma et al. (2003) 
criticised the use of standard QOL questionnaires with this population suggesting 
that they may not be valid or reliable due to insufficient knowledge of the 
experience of recovering from and/or living with a TBI. They argued that until the 
major impacts and struggles of TBI are fully explored, the QOL measures may be 
unreliable and invalid with this population (DePalma et al., 2003). DePalma et al. 
(2003) suggested that in this population, family members/caregivers should be 
included in the rating of QOL. This is because there is often a significant disruption 
in the family life and that in some instances, the person with a TBI reports no 
problems in coping whereas the family members describe many difficulties coping 
(DePalma et al., 2003). 
 
Learning Disabilities 
 
Problems with the use of self-report QOL measures in people with learning 
disabilities are well documented in the literature. The research literature suggests 
that people with learning disabilities have specific problems with certain types of 
questioning styles in relation to item content (e.g. quantitative judgements, 
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generalisations), question phrasing (e.g. modifiers), and response format (e.g. 
acquiescence, multiple choice questions) (Finlay & Lyons, 2001).  Finlay and 
Lyons (2001) suggested that many QOL self-report measures include these types 
of questions and that more attention should be paid to establishing the validity and 
target population that the QOL measures are aimed at. Finlay and Lyons (2001) 
summarised the types of difficulties with questions in QOL questionnaires and the 
possible actions that can be taken to alleviate them (reproduced in table 1). These 
‘actions’ are considered in relation to the QOL measurement in schizophrenia in 
the discussion section of the research paper and appendix 4.1. 
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Table 1. Summary of difficulties in questioning people with learning disabilities and 
possible actions to alleviate them (reproduced from Finlay & Lyons (2001))    
 
Problem Area Specific problems Possible Action 
Question content Quantiative judgements Avoid Likert scales and 
questions of degree and 
frequency.  Use pre-test 
screening questions about 
concrete events for which 
frequency is known. 
 Time questions 
Comparisons 
 
Socially reflective 
questions 
Abstract or general 
concepts 
Use significant events as 
markers. 
Ask about each element 
separately. 
Check meaning of answer. 
Check meaning of answer. 
Use concrete situations or 
events. 
Allow that people may not be 
able to make generalized 
judgements. 
 Psychiatric symptoms 
 
Irrelevant content 
Avoid symptoms difficult to 
understand or describe. 
Elicit item content from 
appropriate populations.   
Beware of basing scales on 
those for general population. 
 Labels 
Sensitive content 
Check understanding. 
Be aware of the difficulties.  
Ask about specifics rather than 
generalities.  Stress that 
information will not be shared 
with carers. 
Question phrasing Negative wordings Avoid adding no or not to 
positive phrasings.  Use 
negative form of words. 
 Modifiers Avoid modifiers, particularly at 
end of sentences.  Check 
meaning. 
 
 
 35 
Problem Area Specific problems Possible Action 
 Subject-object confusion 
and passive phrasings. 
Question not understood 
Be aware of questions where 
this is possible- check 
meaning. 
Keep question structure 
simple, avoid technical 
vocabulary. 
Write alternative phrasings and 
probes into questionnaires. 
Response format Yes-no questions Avoid modifiers and complex 
question structures. 
Include “don’t know” option. 
Check meaning by asking for 
examples and probing further 
(use scripted probes). 
Have pre-interview to check 
how person exhibits 
uncertainty or responds to 
false suggestions. 
 Multiple-choice format Break down into two either-or 
stages. 
Use picture only if meaning is 
clear. 
Avoid Likert scales and 
offering multiple options. 
 Understanding or 
classifying responses 
Tape record interviews. 
Allow scorer to record 
“other/uncodeable” responses 
in questionnaires. 
Return to question later. 
Psychometric 
properties 
Factor structure Do not assume that this is the 
same as for the general 
population. 
 Target population New questionnaires must 
clearly report sample selection 
criteria.  Use test of verbal 
ability. 
 
Appendix 1.4: Validity and reliability of QOL reporting in schizophrenia 
 
Research on the subjective QOL of people with schizophrenia has produced mixed 
conclusions concerning the validity and reliability of the reports. Some of the 
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studies reported that schizophrenia participants underestimated their psychosocial 
functioning, whilst others suggested that their QOL estimates were 
disproportionately high, or just accurate (Weissman, Prusoff & Thompson, 1978; 
Glazer, Aaronson, Prusoff & Williams, 1980; Sullivan et al., 1991). 
 
The reliability of QOL reports has been assessed on measures such as the Quality 
of Life Interview (QOLI) (Lehman, 1988). When the QOLI’s reliability was assessed 
on 500 patients with severe and enduring mental illness, internal and test-retest 
reliability were reported to be ‘satisfactory’ (Prince & Prince, 2001). Vorunganti, 
Heslegrave, Awad and Seeman (1998) used correlational analysis in order to 
assess the reliability and validity of the subjective QOL reports given by 
schizophrenia patients. Positive and statistically significant correlations were found 
for the reliability of QOL self reports over consecutive weeks for the Sickness 
Impact Profile (SIP) (Bergener, Bobbit, Carter & Gibson, 1981) (r= 0.8 - 0.87, 
p<0.0001) and the Gurins Global QOL scale (Gurin, Verhoff & Feld, 1960) (r = 0.68 
- 0.87, p<0.0001). These findings suggest that schizophrenic patients’ subjective 
QOL reports were highly consistent over repeated measurements on global and 
multi-dimensional measures (Vorunganti et al., 1998). Inconsistent with other 
studies (e.g. Wong et al., 2005; Logsdon et al., 2002), the severity of schizophrenic 
symptoms and cognitive deficits did not influence the reliability of the QOL self 
reports in their study. 
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Vorunganti et al. (1998) found that the subjective QOL measures (SIP and Gurin’s 
Global QOL measure) correlated significantly with each other (r = 0.55-0.89, 
p<0.0001) (Vorunganti et al., 1998). They found that the clinicians ratings on global 
and domain specific measures (Social Performance Schedule (SPS) (Stuart & 
Wykes, 1987) and Global Assessment Scale of Functioning (GAF) (Endicott, 
Spitzer, Fleiss & Cohen, 1976) correlated significantly (r= 0.83-0.86, p<0.0001) 
(Vorunganti et al., 1998). They also found that the schizophrenic patients ratings 
on the multidimensional nature of the SIP correlated with the clinicians rating ( with 
SPS, r=0.40-0.52, p<0.0001; with GAF, r= 0.35-0.54, p<0.0001). However, global 
estimates on Gurin’s QOL measure correlated weakly with clinicians ratings (with 
SPS, r= -0.15, p<0.28; with GAF, r= 0.21-0.28, p<0.03) (Vorunganti et al., 1998). 
Vorunganti et al. (1998) concluded that patients and clinicians judgement of QOL 
concurred more with structured measures than global measures (Vorunganti et al., 
1998). 
 
The Vorungati et al. (1998) study was limited in terms of its sample. The sample 
was homogeneous in terms of symptom severity, treatment compliance and 
psychosocial functioning (Vorunganti et al., 1998). This appears to be common 
problem in schizophrenia research in that the extremely psychotic patients are 
often non-compliant and not willing to be studied (Schreiber, Breier & Pickar, 
1990). Another limitation with the Vorunganti et al (1998) study was that it did not 
have a control group. Buckley, O’Callaghan, Larkin and Washington (1992) 
highlighted the difficulty in identifying an appropriate control group in schizophrenia 
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studies in that it is very difficult to differentiate between the consequences of the 
condition and the person’s pre-morbid characteristics.  
 
Appendix 1.5: Cognitive impairments associated with schizophrenia 
 
Memory impairments 
 
Memory is one of the major impairments that have been associated with 
schizophrenia. Memory impairments have been demonstrated to be common and 
disproportionate to the overall level of intellectual impairment (Gold, Randolph, 
Carpenter, Goldberg & Weinberger, 1992). The specificity of the memory 
impairment remains unclear; however some aspects of memory may be more 
affected than others (Aleman, Hijman, De Haan & Kahn, 1999). For example, 
memory for long-term declarative information has been shown to be significantly 
more impaired than short-tem memory (e.g. digit span exercises) (Koh, Kayton & 
Peterson, 1980). Heaton et al. (1994) suggested that in people with schizophrenia, 
it is the encoding of information, rather than recognition and retrieval that is 
affected. However, other studies that have used multiple memory tasks and 
assessments have shown that the memory impairments involve many different 
processes (Landra, Orbeck & Rund 1993; Rund, 1989; Saykin et al., 1991). 
 
Aleman et al. (1999) conducted a meta-analysis of 70 studies that reported 
measures of long-term memory (free recall, cued recall, and recognition of verbal 
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and non-verbal material) and short-term memory (digit span).  The results indicated 
that schizophrenia and memory impairments were significantly associated (Aleman 
et al., 1999). This meta-analysis suggested that the memory impairments were 
wide ranging across tasks, such as level of retrieval support (free recall, cued 
recall, or recognition), stimulus type (verbal versus non-verbal), and retention 
interval (immediate versus delayed) (Aleman et al., 1999). Heinrichs and Zakzanis 
(1998) meta analysis compared schizophrenia patients and normal subjects on a 
range of memory assessments. They found moderate to large effect sizes for 
memory variables that included verbal and non-verbal long-term memory 
assessments (Heinrichs & Zakzanis, 1998). 
 
Several researchers (Baddeley, Thornton, Chua & McKenna, 1996; Feinstein, 
Goldberg, Nowlin & Weinberger, 1998; Riutort, Cuervo, Danion, Peretti & Salame, 
2003) have suggested that autobiographical memory disturbances contribute to the 
symptoms of schizophrenia. Autobiographical memory includes personal semantic 
memory (knowledge of personal facts) and episodic memory (recall of specific 
events). It is not known whether this is a specific deficit, due to a co-morbid 
depression or is part of a general long-term memory impairment in people with 
schizophrenia (Wood, Brewin & McLeod, 2006).  
 
Research into brain pathology has shown that encoding and consolidation 
difficulties may be associated with hippocampus and temporal lobe dysfunction 
(Squire, 1992; Hijaman, 1996). Brain imaging techniques have shown reduced 
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volume or pathology in those areas (Lawrie & Abukmeil, 1998). The frontal lobe 
systems, which may be affected in schizophrenia, have been shown to be involved 
in active retrieval of declarative memories (Wheeler, Stuss & Tulving, 1995; 
Ungerleider, 1995). 
 
Frith (1984) suggested that the memory impairments seen in schizophrenia 
patients are a consequence of the anticholinergic drugs that they are treated with. 
He reported that when Hyoscine (an anticholinergic medication) was intravenously 
administered, it impaired retention of word lists and delayed testing (Frith, 1984). 
He found that the ability to learn new material was impaired, but material acquired 
before drug administration was not affected (Frith, 1984). Frith (1984) also reported 
that Benzodiazepines (e.g. Diazepam, Nitrazepam) affect memory in a similar way 
to the anticholinergic medications. Syndulko et al. (1981) found that 10 weeks of 
treatment with Benztropine Mesylate (CogentinTM), four times a day significantly 
impaired word-list acquisition in comparison to placebo patients. Tune, Strauss, 
Lew, Breitlinger and Coyle (1982) compared schizophrenia patients receiving a 
typical regime of neuroleptics plus anticholinergics. They found a significant 
inverse correlation between word-list recall and serum levels of anticholinergic 
drug: high levels of serum were associated with poor performance (Tune et al., 
1982). 
   
Aleman et al. (1999) meta-analysis compared the memory performance of 
unmedicated with medicated groups. They found that medication status was not 
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associated with memory impairment, however, these analyses only considered 
conventional neuroleptics. Further support for neuroleptic medication not impairing 
the cognitive performance of people with schizophrenia has been provided 
(Goldberg & Weinberger, 1996; Mortimer, 1997; Riley et al., 2000). Some of the 
atypical antipsychotics (e.g. Risperidone and Clozapine) have shown beneficial 
effects on memory (Green et al., 1997; Keefe, Silva, Perkins & Lieberman, 1999). 
 
Executive functioning impairments 
 
Most studies of people with schizophrenia have shown impaired ability on 
executive functioning tasks when compared with normal healthy controls 
(Blanchard & Neal, 1994; Kinney, Yurgelm-Todd, Waternaux & Mattysee, 1994). 
Blanchard and Neale (1994) found that compared with the normal healthy controls, 
patients with schizophrenia were significantly impaired (t=2.87, df 41, p<0.01) on 
executive functioning assessments that included the Wisconsin Card Sorting Test 
(WCST) (Heaton, 1981) and the Controlled Word Association Test (Benton & 
Hamsher, 1976). Kinney et al. (1994) found significant impairments in their 
schizophrenic sample on the Trail Making Test (Reitan & Wolfson, 1985) when 
compared to normal controls. The Trail Making Test (Reitan & Wolfson, 1985) 
purports to assess alternate mental sets and attention, a higher cortical function 
associated with frontal lobe activity (Kinney et al., 1994).  
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Johnson-Selfridge and Zalewski (2001) conducted a meta-analysis and found that 
on a range of executive functioning tests, people with schizophrenia performed one 
and a half standard deviations below normal control participants. They also found 
that schizophrenic groups performed about 0.40 standard deviations lower than 
other psychiatric groups on executive functioning measures, a moderately large 
effect size (Johnson-Selfridge & Zalewski, 2001). Johnson-Selfridge and Zalewski 
(2001) found that the magnitude of the impairment depended on the measure used 
(i.e. the variation in the measures psychometric properties and multifactorial 
constructs). On the executive functioning measures, duration of illness was not 
related to effect size, but number of hospitalisations was. Johnson-Selfridge & 
Zalewski (2001) suggested that this relationship may be due to the people that 
require more hospitalisations having more severe symptomatology and impaired 
functioning.  A limitation of this meta-analysis was that the impact of anticholinergic 
medication on executive functioning could not be assessed (Johnson-Selfridge & 
Zalewski, 2001). This was due to the numbers of people and dosages given, rarely 
being reported in the literature.  
 
Heinrichs and Zakzanis (1998) found similar effect sizes (when compared to 
normal control participants) on their measures of executive functioning 
assessments. Heinrichs and Zakzanis (1998) reported effect sizes of 0.95 and 0.88 
(absolute effect size and corrected for sample size, respectively) based on the 
WCST (Heaton, 1981) variables, as well as corrected effect sizes based on the 
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Trail Making Test -  B (Reitan & Wolfson, 1985) (0.80), the Stroop Test (Golden, 
1978) (1.11), and the Chicago Word Fluency Test (Milner, 1964) (1.15). 
 
Appendix 1.6: QOL measures reviewed by Wong et al. (2005) 
 
Wong et al. (2005) reviewed three of the ‘most commonly used’ health-related QOL 
measures in order to develop the CapQOL: Short Form 36 Item Health Survey (SF-
36) (Ware, Kosinsky & Dewey, 2000); Quality of Well-Being Scale – Self 
Administered (QWB-SA) (Kaplan, Sieber & Ganiats, 1997); EORTC Quality of Life 
Questionnaire C-30 (EORTC QLQ C-30) (Aaronson, Ahmedzai, Bergman & 
Bullinger, 1993). 
 
SF-36 (Ware et al., 2000) 
 
The SF-36 (Ware et al., 2000) is a multi purpose short-form health survey that has 
36 items. It produces an 8-scale profile of functional health and well-being scores, 
physical and mental health summary measures and a preference based health 
utility index (Ware et al. 2000). The SF-36 is a generic measure, that does not 
target a specific condition and has been used in general and specific populations. It 
has been used to compare the relative ‘burden’ of diseases and/or disorders (Ware 
et al. 2000). 
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The SF-36 can be administered in 5-10 minutes with a high degree of acceptability 
and data quality (Ware, Snow, Kosinsky & Gandek, 1993). Alternative long-form 
measures are reported to take 5-10 times longer to complete due to the number of 
questionnaire items that must be administered (Ware et al. 2000). Empirical 
studies have suggested that the SF-36 provides a practical alternative to longer 
measures, and that the 8 scale profile and summary scales rarely fail to identify 
differences in physical and/or mental health status (Ware et al., 1993; Ware, 
Kosinky & Keller, 1994; Katz, Larson, Phillips, Fossel, & Liang, 1992). 
 
QWB-SA (Kaplan et al., 1997) 
 
The QWB-SA (Kaplan et al., 1997) is another generic measure of health status. It 
includes five parts that assess acute and chronic symptoms, self-care, mobility, 
physical functioning and performance of usual activity. The output is a quality-
adjusted index score between 0.0 (death) and 1.0 (perfect health). The QWB-SA 
includes 58 symptoms whereby respondents answer ‘yes’ or ‘no’ if they have had 
each of the chronic, acute and mental health symptoms over the previous three 
days. The QWB-SA is reported to take approximately 10 minutes to complete 
(Kaplan, Ganiats, Sieber & Anderson, 1998) and has demonstrated stable test-
retest reliability in ‘relatively healthy adults’ (Kaplan et al., 1997). 
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EORTC QLQ C-30 (Aaronson et al., 1993) 
 
The EORTC QLQ-C30 is a cancer-specific, self administered questionnaire for use 
in clinical trials. It contains 30 questions: 9 are multi-item scales representing 
aspects of health related QOL: 5 represent functional scales (physical, role, 
emotional, cognitive and social), 3 are symptom scales (fatigue, pain and nausea) 
6 are mono-item scales describing relevant cancer-orientated symptoms (dyspnae, 
insomnia, appetite, constipation, diarrhoea, financial difficulties) and one item 
forms a global scale (Sneeuw et al., 1998). Apolone, Filberti, Cifani, Ruggiata and 
Mosconi (1998) evaluated the EORTC QLQ-C30 and found ‘substantial 
correlations’ with scales from the SF-36. They reported that the EORTC QLQ-C30 
met all the standards for convergent and discriminant validity and had ‘very high’ 
internal consistency (as measured by Cronbach’s alpha) (Apolone et al. 1998). 
 
Appendix 1.7: The development and structure of the CapQOL 
 
Wong et al. (2005) identified five key areas important in completing subjective QOL 
measures. The areas were identified by a review of the ‘most commonly used’ 
health-related QOL measures (to understand the process of completing items on 
the measures) and subjective QOL measures, and discussion and ‘brainstorming’ 
sessions with professionals who were experienced in QOL, mental capacity 
research and administration. The five areas that were identified as important in 
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addressing whether an individual can complete a self-rated subjective measure are 
detailed below along with a description of how the CapQOL assesses those areas: 
 
Acquiescence 
 
In self-reporting measures, acquiescence is a response bias whereby an individual 
tends to agree with items, despite their content (Rust & Golomok, 1999). The 
CapQOL assesses if an individual is acquiescent by asking questions about two 
situations that are mutually exclusive (‘Do you live alone now?’ and ‘Do you live 
with other people now?’). If the individual answers ‘yes’ to both questions, they are 
judged to be ‘acquiescent’ (Wong et al., 2005). 
 
Consistency  
 
This area evaluates whether an individual gives consistent answers to any QOL 
measure and is used to assess the validity of responses. The CapQOL uses two 
open-ended questions to assess if an individual gives inconsistent responses. 
Close-ended questions were not included because it was though that they might 
elicit consistent, but acquiescent responses (Wong et al., 2005). The open-ended 
questions are concerned with an individuals’ favourite singer and the amount of 
television they watch each day. The same question is presented again at the end 
of the CapQOL and if the individual gives a different answer, they are identified as 
inconsistent responders (Wong et al., 2005). 
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Understanding of the 5-point scale  
 
Many QOL measures use a 5-point likert scale, therefore an individual needs to 
understand how it works (Wong et al. 2005). The CapQOL asks respondents to 
rate two scenarios on a 5-point scale that ranges from ‘very unhappy’ to ‘very 
happy’. The two scenarios differ in that one is favourable (being given their 
favourite food), whilst the other scenario is relatively neutral (watching the weather 
report). The different scenarios attempt to ‘prime’ an individual toward expressing 
positive and neutral feelings respectively. The neutral scenario assesses recency 
and primacy biases, whereby an individual chooses either the first or last option 
(Perry & Felce, 2002). The two scenarios assess if an individual can imagine and 
appraise different feelings on a 5-point scale. If they do not respond to the 
favourable scenario with a positive response, or the neutral scenario with a neutral 
response, without a good reason, they are regarded as not having an 
understanding of a 5-point scale (Wong et al., 2005). 
 
Understanding of and values attached to each domain  
 
Wong et al. (2005) argued that a respondent needs to be able to understand what 
a domain is and what is considered desirable within a domain if they are to 
complete a subjective QOL measure validly. The CapQOL uses two domains that 
are often used in subjective QOL measures: economic status and relationship to 
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others. According to their own standards, respondents are asked what would be 
the best and worst situations they could imagine within each domain. Those 
respondents that give vague or irrational/delusional answers are considered to 
have impaired understanding of QOL domains (Wong et al., 2005). 
 
Awareness of own situation and comparison with standard/desirable 
 
Wong et al. (2005) argued that a respondent needs to be able to appraise their 
own situation and evaluate it within the context of the continuum between their 
‘worst imaginable state’ to the ‘best imaginable state’. After the respondent has 
described their ‘best’ and ‘worse’ extremes on the economic status and relationship 
with others domains, they are shown a 9-point scale on a continuum from ‘worst 
imaginable’ to ‘best imaginable’ situation. The respondent is asked to select which 
number represents their situation within the domains and then to explain their 
choice. This gives the assessor the opportunity to understand the reason behind 
the respondent’s judgement, their awareness of their own situation and ability to 
compare their current situation with their subjective ‘best’ and ‘worst’ extremes 
(Wong et al. 2005). Those respondents that answer with vague or 
irrational/delusional thinking are considered to lack the ability to compare their 
current situation with their subjective best and worst situations. 
 
In addition to assessing the five areas, the CapQOL includes a final ‘global score’. 
This uses a 5-point scale and is scored by the assessor on their impression of the 
 49 
respondents’ ability to complete the CapQOL, based on how they performed on the 
previous five areas. A score of 4 or 5 would indicate that they believe the 
respondent has the capacity to give valid and reliable answers on a QOL measure. 
A score of 1 or 2 would indicate that they believe the respondent lacks the capacity 
to give valid and reliable answers on a QOL measure. A score of 3 would indicate 
borderline ability.  
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Appendix 1.8: The capacity to report subjective quality of life inventory 
(CapQOL)  (Wong et al. (2005) 
 
Capacity to Report Subjective Quality of Life Inventory 
(CapQOL) 
 
 
1. Do you live on your own now? 
 
 
 
2. Who is your favorite singer? 
 
 
3. How much TV do you watch each day? 
 
 
 
4. What is your favorite food? 
 
 
 If I give you      (fill in the favorite food) now, please 
describe how you feel by choosing one of the five boxes below. 
 
 
 
 
 
5. If you switch on the TV and the weather report is on, how would you feel? 
Please describe how you feel by choosing one of the five boxes below. 
 
 
 
 
 
 
 
 
 
 
 
 
neither unhappy nor happy happy very happy unhappy very unhappy 
neither unhappy nor happy happy very happy unhappy    very unhappy 
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Output           
   0  1  2 
 
For the question on favorite food (supposed to induce positive feelings), the expected range of output is: (neither happy nor 
unhappy, happy, very happy) 
For the question on weather report (a supposedly neutral event), the expected range of output is: (unhappy, neither happy 
nor unhappy, happy) 
 
0 Answers beyond the expected range are given to both questions, without a reasonable explanation (Example of a 
reasonable explanation: ‘very unhappy’ about the weather report because there are thunder storms and an outing has 
to be cancelled.) 
1 An answer beyond the expected range is given to one question only; the answer given to another question is within 
the expected range. 
2 Answers within the expected range are given to both questions. 
 
 
 
6. Do you live with other people now? 
 
 
Acquiescence (Refer to Q1)       
   0  1 
 
0 Identical answers are given to the two mutually exclusive questions. 
1 Different answers are given to the two mutually exclusive questions. 
 
7. People have different standards and views about one’s economic status. 
According to your own standard, what would be the best economic status you 
can think of? What would be the worst economic status you can think of? 
 
the worst:                 the best: 
 
 
 
 
 
 
 
 
 
 
 
 
Understanding of Domain: Economic Status 0  1  2 
 
0 No subjective description of the best and worst expectations of the domain given; or the patient can describe own 
expectations of the domain, but which seem to be based on delusional beliefs or psychotic experiences. 
1 Patient seems ambivalent, gives only vague descriptions of own expectations of the domain; or answers given cannot 
allow the examiner to determine whether they represent delusional beliefs or psychotic experiences. 
2 Patient gives clear descriptions of own expectations of the domain, which are not based on any delusional belief or 
psychotic experience. 
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8. The line below represents the worst economic status to the best economic 
status that you just described. Please circle one of the numbers below (1 to 9) 
to represent your economic status now. 1 represents the worst economic 
status, and 9 represents the best economic status. 
 
 
 
 
 
 
Why should your current economic status be marked there? 
 
 
 
 
 
 
 
 
Awareness of Own Situation and Comparison: 
Economic Status         
  0  1  2 
 
0 Patient cannot locate his/her current situation within the spectrum; or the patient can locate his/her current situation 
within the spectrum, but the reason given seems to be based on delusional beliefs or psychotic experiences. 
1 Patient can locate his/her current situation within the spectrum, but the reason given is vague or does not allow the 
examiner to determine whether it represents delusional beliefs or psychotic experiences. 
2 Patient can locate his/her current situation within the spectrum, and can give clear reason, which does not indicate 
any delusional belief or psychotic experience. 
 
 
9. People have different standards and views about relationship with others. 
According to your own standard, what would be the best and the worst 
relationships with others you could imagine? 
 
the worst:        the best: 
 
 
 
 
 
 
 
 
 
1 2 3 4 5 6 7 8 9 
the worse      the best 
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Understanding of Domain: 
Relationship with Others        
 0  1  2 
 
0 No subjective description of the ideal and worst expectations of the domain 
given; or the patient can describe own expectations of the domain, but which 
seem to be based on delusional beliefs or psychotic experiences. 
1 Patient seems ambivalent, gives only vague descriptions of own expectations 
of the domain; or answers given cannot allow the examiner to determine 
whether they represent delusional beliefs or psychotic experiences. 
2 Patient gives clear descriptions of own expectations of the domain, which are 
not based on any delusional belief or psychotic experience. 
 
 
 
10. The line below represents the worst relationship with others to the best 
relationship with others that you just described. Please circle one of the 
numbers below (1 to 9) to represent your relationship with others now. 1 
represents the worst relationship with others, and 9 represents the best 
relationship with others. 
 
 
 
 
 
 
Why should your current relationship with others be marked there? 
 
 
 
 
 
Awareness of Own Situation and Comparison: 
Relationship with Others        
 0  1  2 
 
0 Patient cannot locate his/her current situation within the spectrum; or the patient can locate his/her current situation 
within the spectrum, but the reason given seems to be based on delusional beliefs or psychotic experiences. 
1 Patient can locate his/her current situation within the spectrum, but the reason given is vague or does not allow the 
examiner to determine whether it represents delusional beliefs or psychotic experiences. 
2 Patient can locate his/her current situation within the spectrum, and can give clear reason, which does not indicate any 
delusional belief or psychotic experience 
. 
 
11. Could you tell me once again who your favorite singer is? 
 
 
1 2 3 4 5 6 7 8 9 
the worse      the best 
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12. Could you tell me once again how much TV you watch each day? 
 
 
Consistency (Refer to Q2, Q3)       
   0  1 
 
0 Inconsistent answers are given to the two sets of questions. 
1 Consistent answers are given to the two sets of questions. 
 
 
 
Global Score 1  2  3  4  5 
 
1 Patient seems to be unable to understand any QoL domain. Despite the provision of maximum assistance and 
guidance from the examiner, no description or explanation of each QoL domain can be given; or it is clearly based on 
delusional beliefs or psychotic experiences. Any answer given by the patient when administering the QoL assessment 
tools is expected to be highly invalid and unreliable. 
 
2 Patient shows only a limited understanding towards the QoL domains. Although the patient can give some 
descriptions and explanations of each domain, they do not allow the examiner to determine whether the patient’s 
reasoning process represents delusional beliefs or psychotic experiences. Patient’s ability and capacity to complete 
the QoL assessment tools would be questioned. 
 
3 Patient only has a fair understanding of the QoL domains. Despite the examiner’s effort to provide appropriate 
assistance and guidance, only vague descriptions and explanations concerning each domain can be given. Patient 
may not have the ability and capacity to be administered the QoL assessment tools. 
 
4 Patient shows a good understanding of the QoL domains. Reasons and explanations are given only with some 
assistance and guidance from the examiner. The patient would still able and capable to complete the QoL 
assessment tools. 
 
5 Patient understands and describes all QoL domains very well. No unclear description or explanation is given. 
Minimum assistance or guidance is required from the examiner. The patient clearly has the ability and capacity to 
successfully complete the QoL assessment tools. 
 
 
Copyright © 2001 Dr JGWS Wong, Mr Erik Cheung, Mr Leung Kwok Fai, Dr EYH Chen 
 
Appendix 1.9: Negative symptoms in schizophrenia (and their associated 
problems) 
 
The associations between negative symptoms and cognitive impairments in 
schizophrenia are widely reported in the research literature (e.g. Buchanen et al., 
1994; Liddle, 1987; Liddle & Morris, 1991; Perlick, Mattis, Stasny & Silverstein, 
1992). Negative symptoms have been linked with deficits involving intelligence, 
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executive function and memory (Berman, et al., 1997; Cuesta & Peralta, 1995; 
Himelhoch, Taylor, Goldman & Tandon, 1996). Positive symptoms have not been 
associated with cognitive impairments (Basso, Nasrallah, Olson & Bornstein, 
1998). 
 
There are inconsistencies in the research literature with some studies suggesting 
that executive function deficits are not related to negative symptomatology (Basso 
et al., 1998; Van der Does, Dingemans, Linszen, Nugter & Scholte, 1993). These 
inconsistencies in the research have been attributed to differences between patient 
samples and the differing types of neuropsychological assessments used across 
studies (Basso, Bornstein & Lang, 1999). Lezak (1995) suggested that different 
measures of executive function have differential sensitivity in detecting 
impairments across a variety of brain regions. 
 
Studies of brain pathology have found that negative symptoms are related primarily 
to fronto-temporal abnormalities (Schroeder, Buchsbaum, Siegel, Geider & 
Niethammer, 1995), suggesting that negative symptoms may be related to higher-
cognitive functioning deficits such as attention, intellect and concept formation 
(Basso et al., 1999). Basso et al. (1999) studied correlations of positive and 
negative symptomatology across a range of neuropsychological tests and found 
that increasing severity of negative symptoms were related to decreased 
performance across a broad range of neuropsychological functioning (Basso et al., 
1999). Negative symptoms tended to achieve moderate to large correlations with 
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neuropsychological function and were related to intelligence, conceptual reasoning, 
attention span, sustained attention, memory and sensory motor function (Basso et 
al., 1999).  
 
The Basso et al. (1999) study contradicted previous research that negative 
symptoms are associated primarily with executive dysfunction (Berman et al., 
1997). Basso et al. (1999) concluded that because their findings indicated that 
negative symptoms were associated with poor performance on most measures of 
higher cognitive function, negative symptoms were associated with wide spread 
cerebral dysfunction rather than being restricted to the left hemisphere  (Basso et 
al., 1999). 
 
It has been suggested that with negative symptoms being associated with frontal 
lobe dysfunction, this may account for retrieval deficits (Liddle & Morris, 1991).   In 
the Aleman et al. (1999) meta-analysis, the only potential moderator variable that 
they found for a schizophrenia-memory association was negative symptoms. They 
found a small effect size, however this finding is consistent with previous research 
that had examined the relationships between negative symptoms and cognitive 
function in schizophrenia (Basso et al., 1999; Liddle, 1987; Liddle & Morris, 1991).  
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Appendix 2.1: Description and justification of the measures that were used 
 
National Adult Reading Test 2nd Edition (NART) (Nelson & Willison, 1992) 
 
Nelson et al. (1990) concluded that word reading ability is unaffected in chronic 
schizophrenia. The most commonly used word reading test to predict pre-morbid 
IQ levels in people with schizophrenia is the NART (Russell et al., 2000). The 
validity of the NART as an estimate of premorbid IQ was assessed in 62 patients 
(35 long-stay hospitalised, 29 community-based) who were administered both the 
NART and WAIS-R (Crawford et al., 1992). They found a significant discrepancy 
between scores on the NART and WAIS-R, with the NART estimating IQ higher 
than the WAIS-R. Crawford et al. (1992) concluded that a decline had occurred in 
the patients that were assessed and recommended that the NART was therefore a 
valid and useful assessment of pre-morbid IQ (Crawford et al., 1992).  
 
O’Carroll, Mofoot, Ebmeir and Goodwin (1992) replicated Crawford et al. (1992) 
finding in that NART scores were higher than WAIS-R in their schizophrenia 
sample. They also compared NART performance between acutely ill unmedicated 
schizophrenics and non-schizophrenic psychotics with controls (with similar 
demographics thought to affect NART performance) (O’Carroll et al., 1992). No 
significant differences were found between the three groups. O’Carroll et al. (1992) 
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concluded that the pronunciation of irregular words is unaffected in the acute 
phases of psychosis.  
 
Smith, Roberts, Brewer and Pantelis (1998) examined the test-retest reliability of 
the NART in a schizophrenia sample over a six-month period. Their sample was 
assessed on the NART at baseline, six weeks and six months. No significant 
differences between the scores were found (Smith et al., 1998). Smith et al. (1998) 
concluded that NART-estimated premorbid IQ scores were stable over time. 
 
Russell et al. (2000) selected a sample of adults with schizophrenia who had their 
IQ assessed as children using the Weschler Intelligence Scale for Children (WISC) 
(Weschler, 1949) or the Revised Version (WISC-R) (Weschler, 1974). They found 
no significant differences between their childhood (WISC or WISC-R) and adult 
(WAIS-R) estimates of IQ, but they did find a significant difference between those 
indices and NART estimates of IQ, especially when participants IQ deviated from 
general population means (Russell et al., 2000). Russell et al. (2000) suggested 
that NART estimates should be interpreted with caution when IQ scores do not fall 
in the ‘average’ category and that ideally, more than one measure of premorbid 
functioning should be used.   
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Adult Memory Information Processing Battery (AMIPB): Story Recall 
(Coughlan & Hollows, 1985) 
 
The AMIPB is particularly popular in schizophrenia rehabilitation settings due to 
each test having parallel forms. This minimises practice effects if repeated testing 
is required (Allen, Brechin, Skilbeck & Fox, 2007). The Story Recall test is 
designed to assess immediate registration of verbal information and retention over 
time (Coughlan & Hollows, 1985). The test involves the person being read a short 
story, then being asked to recall it immediately and 25-35 minutes later. This 
procedure was derived from the Logical Memory passages of the Weschler 
Memory Scales (WMS) to assess immediate and delayed recall after one hour 
(Coughlan & Hollows, 1985). Coughlan and Hollows (1985) reduced the delay 
recall period of the AMIPB in order to ease administration. 
 
Wood et al. (2006) used the AMIPB to assess memory impairments in their 
schizophrenia sample. They assessed the difference in immediate and delayed 
memory when comparing people diagnosed with schizophrenia and matched 
normal controls. They found that the two groups differed significantly on both the 
immediate and delayed recall tasks with the schizophrenia group performing worse 
(Wood et al., 2006). 
 
The Story Recall Test appears to have face validity and is a procedure commonly 
used in clinical psychology (Lezak, 1995). Coughlan and Hollows (1985) suggested 
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that the Story Recall Test has a clinical rather than theoretical orientation, and 
assesses broad aspects of memory (e.g. retention and learning), not specific 
memory system components. Despite the verbal presentation of the test, it does 
not necessarily mean that it is reflective of verbal memory systems (Coughlan & 
Hollows, 1985). 
 
The inter-test correlations within the AMIPB are mostly highly significant (p<0.001), 
but small (Coughlan & Hollows, 1985). This small correlation may be due to the 
different tests focusing on differing aspects of memory skills (Coughlan & Hollows, 
1985). The sensitivity of the Story Recall Test has been assessed when comparing 
neurological patients with generalised cerebral dysfunction, with normal healthy 
controls. At the 10th and two standard deviation cut-off, the incidence of 
neurological patients’ poor performance was significantly higher than normal 
healthy controls (Coughlan & Hollows, 1985). 
 
Hayling & Brixton (H&B) Tests (Burgess & Shallice, 1997) 
 
The H&B Tests are an example of the newer type of executive functioning 
assessments that are designed to predict social and functional ability (ecological 
validity) and are less focused on discriminative ability for diagnosis (Wood & Liossi, 
2006). The H&B Tests involve procedures that are sensitive to executive 
functioning, thought to be impaired after damage to the frontal lobes (Wood & 
Liossi, 2006). The Hayling Test measures initiation speed and response 
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suppression, while the Brixton Test measures rule detection (Wood & Liossi, 
2006).  
 
The Dysexecutive Questionnaire (DEX), a supplementary measure of the 
Behavioural Assessment of Dysexecutive Syndrome (BADS) (Wilson,1996), is 
considered to be an ecologically valid measure of dysexecutive symptoms (Wood 
& Liosi, 2006). Bajo and Nathaniel-Jones (2001 as cited in Wood & Liossi, 2006) 
found that Hayling part 1 (intiation) correlated weakly (.21-.28) with all three DEX 
factors (response suppression, intentionality, and executive memory) and that the 
Brixton Test correlated significantly with the executive memory factor (.40). Hayling 
part 2 (response suppression) did not correlate with scores on any of the three 
DEX factors (Wood & Liossi, 2006). 
 
Stokes and Bajo (2003) evaluated the associations between the H&B, BADS and 
DEX. They found that when IQ was not partialled out, the H&B Tests did not 
correlate with any factors on the DEX (Stokes & Bajo, 2003). However, when 
WAIS-III (Weschler, 1999) correlations were partialled out, the BADS did not 
correlate with the DEX, however, a number of parts of the H&B Tests parts 
correlated with DEX measures. Stokes and Bajo (2003) concluded that the H&B 
Tests showed a greater specificity than the BADS in the measurement of executive 
functioning when IQ was partialled out. Marczewski, Van der Linden & Laroi (2001) 
demonstrated moderate bivariate correlations between the Hayling Test and other 
measures of executive functioning.  
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There is evidence that areas other than the frontal lobes contribute to performance 
on the Hayling Test (Andres & Van der Linden, 2000; Collete et al., 2001). 
Functional imaging has demonstrated a left hemisphere bias for the Hayling Test; 
the cortical areas for verbal initiation and suppression have shown higher activation 
in the left frontal areas (Collete et al., 2001).  
 
Marczewski et al. (2001) demonstrated moderately strong bivariate correlations 
between the Brixton Test and the Tower of London Tests in their schizophrenia 
sample. Patients with anterior lesions have produced more errors on the Brixton 
Test than posterior lesions and controls (Burgess & Shallice, 1997). De Frias, 
Dixon and Strauss (2006) argued that evidence for construct validity was found 
when they discovered that the Brixton Test loaded with other executive functioning 
tasks on the same factor. 
 
Reverberi, Lavaronni, Gigli, Skrap and Tim (2005) demonstrated that the Brixton 
Test is more sensitive to left than right hemisphere damage. Their patient sample 
with left frontal lesions were significantly impaired on the Brixton Test, but right 
lateral lesion patients made the same number of errors as controls (although they 
made three times more ‘capture errors’, a sign of impaired monitoring processes) 
(Reverberi et al., 2005). These findings indicate that performance on the Brixton 
Test may differentiate between processes mediated by the left lateral frontal cortex 
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(inductive reasoning, monitoring, and working memory), and processes for the right 
lateral cortex (monitoring and checking) (Reverberi et al., 2005). 
 
Chayton and Schmitter-Edgecombe (2003) have argued that the ecological validity 
of executive functioning tests varies according to the seriousness of the 
neurological problem and the clinical population. IQ appears to contribute strongly 
to performance on executive functioning tests. This is supported by significant 
correlations between tests of executive functioning (i.e. Hayling Test, Zoo Map, 
Key Search) and WAIS-III (Wood & Liossi, 2006). Rabbit (1997) suggested that 
executive functioning may represent a cluster of components that have not been 
successfully linked together and have no obvious hierarchy. It also seems likely 
that existing tests involve several executive and non-executive processes. Wood 
and Liossi (2006) suggested that it may be impossible to develop a pure test of 
executive functioning, because executive function involves the coordination of 
several cognitive domains at the same time. 
 
Positive and Negative Syndrome Scale (PANNS) (Kay, Fizbein & Opler, 2000) 
 
The Positive and Negative Scales of the PANNS are reported to be internally 
consistent and highly reliable when assessed by test-retest, split-half and 
coefficient alpha (Kay et al., 2000). PANNS ratings have been shown to be highly 
correlated with the Andreasen method for evaluating positive (r = .77) and negative 
(r = .77) symptoms (Kay, Fizbein & Lindenmayer, 1988).  The inter-rater reliability 
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of the PANNS has been reported in the range of .83 to .87 (Kay et al., 2000). Kay 
and Singh (1989) demonstrated test-retest correlations of r=.37 (positive scale) 
and r=.43 (negative scale) in their ‘subacute’ schizophrenia sample after a 3-4 
month delay. Kay et al., (1987) demonstrated test retest coefficients of r=0.8 
(positive scale) and r=0.68 (negative scale) over 3-6 months in their chronic 
schizophrenia sample. 
 
The PANNS manual presents a five factor, ‘pentagonal’ model of schizophrenia. 
The five factors are: Positive, Negative, Dysphoric Mood, Activation, and Autistic 
Preoccupation (Kay et al., 2000).  External validity of the PANNS and the five 
factor-model have been assessed by correlations with socio-demographic 
variables, DSM-IV (subtype) diagnoses, clinical characteristics and drug use (Van 
der Oord et al., 2006). Van der Oord et al. (2006) demonstrated significant 
correlations with the five PANNS scales, suggesting that they measure meaningful 
aspects of schizophrenia. These correlations varied, suggesting that the scales 
assessed differing aspects of the schizophrenia condition (Van der Oord et al., 
2006). Internal consistency on the scales, apart from the Dysphoric Mood scale, 
were reported to be ‘satisfactory’ using Cronbach’s Alpha and in the range of 0.70 
to 0.85 (Van der Oord et al., 2006).  
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Appendix 2.2: NHS Ethics and Research and Design committees’ approval 
letters 
Nottingham Research Ethics Committee 1 
Standard Court 
Park Row 
Nottingham 
NG16GN 
 
Telephone: 01159123344 Facsimile: 01159123300 22 September 2006 
 
Mr N McGrath 
Trainee Clinical Psychologist 
Lincolnshire Partnership (NHS) Trust 
Mid-Trent Doctorate in Clinical Psychology, University of Lincoln 
Brayford Pool 
Lincoln, LN6 7TS 
 
Dear Mr McGrath, 
 
Full title of study: The use of the CapQOL (capacity to report subjective 
quality of life inventory) with an inpatient poplation of 
people with Severe and Enduring Mental Illness (SEMI). 
REC reference number: 06/Q2403/127 
 
Thank you for your letter of 10 September responding to the committee’s request 
for information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the 
Vice Chair. 
 
Conformation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion 
for the above research on the bases described in the application form, protocol and 
supporting documentation as revised. 
 
Conditions of approval 
 
The favouravle opinion is given provided that you comply with the condition set out 
in the attached document. You are advised to study the conditions carefully. 
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
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Document Version Date 
Application 1 16 July 2006 
Investigator CV  16 July 2006 
Investigator CV 1 01 January 2006 
Protocol 3 16 July 2006 
Letter from sponsor  06 September 2006 
Peer review   
Questionnaire: CapQOL   
Questionnaire: NART   
Questionnaire: Hayling and Brixton Tests   
Questionnaire: AMIPB   
Questionnaire: SCI-PANSS   
Participant Information Sheet 4 10 September 2006 
Participant Consent Form 4 10 September 2006 
Response to Request for Further Information  10 September 2006 
Supervisors Signature Page  07 August 2006 
 
Research governance approval 
 
You should arrange for R&D department at all relevant NHS care organisations to 
be notified that the research will be taking place, and provide a copy of the REC 
application, the protocol and this letter. 
 
All researchers and research collaborators who will be participating in the research 
must obtain final research governance approval before commencing any research 
procedures. Where a substantive contract is not held with the care organisation, it 
may be necessary for an honorary contract to be issues before approval for the 
research can be given. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements 
for Research Ethics Committees (July 2001) and complies fully with the Standard 
Operating Procedures for Research Ethics Committees in the UK. 
 
06/Q2403/127  Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project. 
 
Yours sincerely 
 
Dr K Pointon / Ms L Ellis 
Chair / Co-ordinator 
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Email:linda.ellis@rushcliffe-pct.nhs.uk 
 
Enclosures:  Standard approval conditions 
 
 
Copy to: 
 
Judith Tompkins 
University of Lincoln 
Mid-Trent Doctorate in Clinical Psychology, University of Lincoln 
Health, Life and Social Science 
Brayford Pool, Lincoln 
 
R&D Department for NHS care organisation at lead site - -LPT 
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Your ref:                Research and Effectiveness Unit 
NM/AL/18.10.05                     Lincolnshire Partnership NHS Trust  
Our ref:                                                Faculty of Health, Life and Social Sciences 
                                                                                                University of Lincoln 
Date: 18th October 2006                                                                   Brayford Pool 
                                                                                                                     Lincoln 
Mr Noel McGrath                                                                                       LN6 7TS  
Trainee CJinical 
Psychologist 
Lincolnshire Partnership 
NHS Trust                                                                                  Tel: 01522 837030 
Mid Trent Doctorate in 
Clinical Psychology                                              Email:Gill.Thompson@lpt.nhs.uk 
Faculty of Health, Life and 
Social Science 
Brayford Pool 
Lincoln 
LN&7TS 
 
 
Dear Noel 
 
Re:   Project Reference: 06/Q2403/127 
Title of Study:  The use of the CapQOL (capacity to report subjective 
quality of life inventory) with an inpatient population of 
people with Severe and Enduring Mental Illness (SEMI). 
 
Trust approval has now been granted for the above study. In addition to your ethics 
approval we are pleased to notify you that you may now commence your research. 
Please retain this letter to verify that you have Trust approval to proceed. 
 
We may contact you from time to time to monitor progress with your work. If the 
research is terminated or you complete this work, please let the research and 
effectiveness office know so they can amend their records. 
 
Do contact us if you require any further advice. We wish you every success with 
your work. 
 
Yours sincerely 
 
Gill Thompson 
Research and Audit Assistant 
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Appendix 2.3: Rational for re-administration interval and sample size 
 
Re-Administration interval 
 
A 1-2 week interval was chosen for re-administration of the CapQOL. This is 
consistent with the spacing of evaluations in clinical practice and research 
(Vorunganti et al., 1998). Over a 1 week period, Vorunganti et al. (1998) found a 
correlation co-efficient of 0.86 in their stabilised schizophrenia sample. Vorunganti 
et al. (1998) argued that stabilised schizophrenic patients were therefore as 
reliable as patients from general practice studies (e.g. Bergener et al., 1981). 
 
Sample size 
 
The required number of participants was estimated at 28, using a power calculation 
and through consulting the literature. With an effect size (Pearson’s R) of 0.5 
(large), an alpha of 0.05 and a power of 0.8, Barker, Pistrang and Elliott (2002) 
suggested a sample size of 28 would be needed. The literature suggested that 1 in 
10 young, first episode psychosis patients lacked the capacity to appraise their 
subjective QOL according to the CapQOL (Wong et al., 2005). Due to the expected 
greater cognitive impairments present in this study’s population, it was predicted 
that there would be a much higher percentage of participants assessed as lacking 
capacity on the CapQOL (e.g. 30-40%). Therefore a sample size of 28 would 
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produce enough participants that had and had not the capacity as assessed by the 
CapQOL. 
 71 
Appendix 3.1: Data Screening 
 
The histograms presented in figures 2 and 3 indicate that the data was not 
normally distributed. However, the data was obtained from a clinical sample and 
the scale is only designed to detect impaired ability so you might expect the data 
to not be normally distributed.  
                   
Figure 2. Histogram of CapQOL global scores at time 1 
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Figure 3. Histogram of CapQOL global scores at time 2 
 
The Shapiro Wilk test (presented in table 2) was significant indicating again that 
the data was significantly different from a normal distribution at time 1 and time 2.  
 
Table 2. Shapiro Wilk Tests of Normality 
 
  Shapiro-Wilk 
  Statistic df Sig. 
Global Scores: Time 1. .886 23 .013 
Global Scores: Time 2. .858 23 .004 
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The descriptive statistics of the CapQOL global scores at time 1 and time 2 are 
presented in table 3. The Zskew’s were within the range -1.96 - 1.96 (Time 1 = 
0.45, Time 2 = 0.70). This test indicated that data transformation was not 
required.  
 
Table 3. Descriptive statistics for the CapQOL global scores (at time 1 and time 
2) 
 
Statistic Time 1 Time 2 
Median 3 4 
Variance 2.087 1.984 
Range 1 – 5 1 – 5 
Interquartile range 3 3 
Skewness -.218 (s.e. = .481) -.335 (s.e. = .481) 
 
Due to the small sample size (n = 23) and the histograms and Shapiro Wilk Tests 
indicating that the data was not normally distributed, non-parametric correlations 
(Spearman’s rho) were used. 
 
Appendix 3.2: Bland and Altman (1995) method 
 
Bland and Altman (1995) have argued that the correlation coefficient is an 
inappropriate method to analyze the repeatability of a single measurement tool. 
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They suggested an alternative approach based on graphical representations (in 
the form of scatter plots) and simple calculations (Bland & Altman, 1995). The 
Bland and Altman (1995) plot for the CapQOL domain scores at time 1 and 2 is 
presented in figure 4. The plot indicates ‘good’ repeatability of the CapQOL at 
time 1 and 2, with only one of the scores (participant no. 12) falling outside the 
95% confidence interval range. 
6.004.002.00
Average of CapQOL Global Scores at T1 and T2
2.00
0.00
-2.00Di
ffe
re
nc
e b
et
we
en
 C
ap
QO
L 
Gl
ob
al 
Sc
or
es
 at
 
T1
 an
d 
T2
22
21
20
19
18
17
16
15
14
13
12
1110
8
7 6
4
32
1
Mean
+1.96SD
-1.96SD
 
 
 
Figure 4. Difference against average global scores on the CapQOL at time 1 and 
2, with 95% limits of agreement (red lines) 
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Appendix 3.3: χ2  analysis of order of presentation 
 
There was a non-significant effect for order of presentation of the assessments 
and impaired/unimpaired scores on the CapQOL (χ2 (1) = .381, p = .537). All of 
the expected frequencies were above 5. The count and expected count 
frequencies are presented in table 4. 
 
Table 4. Frequency and expected count of order of presentation and impairment 
on the CapQOL 
 Order 1 Order 2 
Impaired Count 5 6 
 Expected Count 5.7 5.3 
Unimpaired Count 7 5 
 Expected Count 6.3 5.7 
  
 
 
Appendix 3.4: Analysis of domain/item statistics 
 
The internal consistency of the CapQOL as measured by Cronbach’s alpha 
(.850) is in the ‘good’ range (values around .8) (Field, 2000). The domain/item 
analysis if an item were deleted (see table 5) indicated that there would only be 
marginal improvements in the reliability of the CapQOL if three domains/items 
were deleted (acquiescence, consistency and understanding of the 5 point 
scale). Domain/item deletion would therefore not substantially improve the 
reliability of an already internally consistent questionnaire. 
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Table 5. Cronbach’s alpha scores if a domain/item were deleted  
 
 Domain/Item 
Cronbach's Alpha if 
Item Deleted 
Global Score .777 
* Acquiescence .862 
* Consistency .855 
* Understanding of 5-point scale .856 
Understanding of domain: economic status .834 
Understanding of domain: relationship with others .798 
Awareness of economic status .810 
Awareness of relationship with others .823 
 
Appendix 3.5: Alternative analysis of the acquiescence and consistency 
domains using the χ2 statistic 
 
As opposed to the other domains, the acquiescence and consistency domains 
are not scored on a continuum and are scored as ‘fail’ (0) or ‘pass’ (1). Therefore 
the associations between the global domain scores and acquiescence and 
consistency domains should be analyzed using the χ2 statistic. The research 
paper reports Spearman’s Correlation Statistics so that the data can be 
compared to the original Wong et al. (2005) study (that used Pearson’s 
Correlations), however, χ2 statistics for the acquiescence and consistency 
domains should have been used. 
 
Due to the small sample size, one of the assumptions of the χ2 Test (that the 
expected frequencies are greater than 5) (Field, 2000) was not met. A non-
significant effect for the association between global scores and acquiescence (χ2 
(4) = 3.407, p = .587) and consistency (χ2 (4) = 7.339, p = .129) was computed. 
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This non-significant effect may be accounted for by the ‘loss of statistical power’ 
resulting from all of the expected frequencies being lower than 5 (Field, 2000). 
 
Appendix 3.6: Principal component analysis data screening 
 
Wong et al. (2005) conducted principle component analysis with varimax rotation 
on their domain scores in order to identify factor structures of the domain scores. 
Screening of the data from this study highlighted that this type of analysis was 
not appropriate. The variable to participant ratio for this study was 1 : 3.3. Kass 
and Tinsley (1979 as cited in Field, 2000) recommend having between 5 and 10 
participants per variable. The Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy was calculated at .598. This indicated that the data was only just 
above the ‘bare minimum’ (.5) and in the ‘mediocre’ range’ for sampling 
adequacy (Kaiser, 1974 as cited in Field, 2000). Finally, the correlation matrix 
indicated that many of the domains did not correlate significantly with each other 
(see table 6). 
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Table 6. Correlation matrix of domain (D) scores 
 
 
  D1 D2 D3 D4 D5 D6 D7 
Spearman 
Correlation 
D1 1.000 .036 -.055 .183 .132 .162 .323 
  D2 .036 1.000 -.240 .133 .500 .436 .324 
  D3 -.055 -.240 1.000 .237 .141 .429 .343 
  D4 .183 .133 .237 1.000 .550 .250 .575 
  D5 .132 .500 .141 .550 1.000 .459 .733 
  D6 .162 .436 .429 .250 .459 1.000 .563 
  D7 .323 .324 .343 .575 .733 .563 1.000 
Sig. (1-tailed) D1   .435 .401 .202 .273 .230 .066 
  D2 .435   .135 .273 .008 .019 .066 
  D3 .401 .135   .138 .260 .021 .054 
  D4 .202 .273 .138   .003 .125 .002 
  D5 .273 .008 .260 .003   .014 .000 
  D6 .230 .019 .021 .125 .014   .003 
  D7 .066 .066 .054 .002 .000 .003   
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Appendix 4.1: Alterations to QOL measurement 
 
The actions suggested by Finlay and Lyons (2001) for QOL measurement in 
learning disabilities populations may generalise to chronic schizophrenia 
populations and enable more of this population to reliably complete QOL 
measures. For example, the CapQOL assesses ‘acquiescence’ using a ‘yes/no’ 
format. 22% of the participant’s failed this domain at the first administration. 
Finlay and Lyons (2001) suggested conducting a pre-interview to check how a 
person exhibits uncertainty and responds to false suggestions. They also 
suggested deleting modifiers and complex question structures in the QOL 
measure. They suggested adding a ‘don’t know’ option to the QOL measure and 
that assessors should check the meaning by asking for examples and probing 
further using scripts. 
 
22% of the participant’s exhibited difficulties using the 5-point Likert scale on the 
CapQOL. Finlay and Lyons (2001) suggested that Likert scales and degrees of 
frequency should be avoided in QOL measurement. The understanding of 
economic status and relationship domains in the CapQOL and in QOL are very 
general/abstract concepts. Respectively, 48% and 57% of the participants had 
difficulties with these domains at the first administration. Finlay and Lyons (2001) 
suggested the inclusion of concrete situations and events in the measures and to 
allow for the possibility that people may not be able to make generalized 
judgements.  
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The awareness of own situation and comparison with standard/desirable 
domains in terms of economic status and relationship with others were 
problematic for 52% and 57% respectively for the participant’s at the first 
administration.  For these types of questions/items, Finlay and Lyons (2001) 
suggested that elements (i.e. own situation, standard/desirable) should be rated 
separately, using a method other than the traditional Likert Scale. 
 
Appendix 4.2: Condition specific vs. general QOL measurement 
 
Two of the health-related QOL measures (the SF-36 and QWB-SA) that were 
reviewed by Wong et al. (2005) in order to develop the CAPQOL were designed 
to be used with any adult population. The other health related QOL measure (e.g. 
EORTC QLQ-C30) that was reviewed was designed for a specific cancer 
population. Some investigators believe that it is necessary to develop QOL 
measures for specific conditions/diseases. It could be argued that schizophrenia 
has very specific outcomes that affect QOL. The types of impaired responding 
(e.g. acquiescence, consistency, understanding and awareness of domains) 
would provide further support for the development of schizophrenia specific QOL 
measures that take into account the responding style of the population. 
 
The counter argument to developing schizophrenia specific QOL measures is 
that all severe and enduring conditions affect overall QOL by affecting functioning 
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and self perceptions of health status. Also, measures that are condition specific 
might fail to capture the unanticipated effects of the condition or its treatment/s. 
The investigator that adopts this argument would therefore be interested in 
understanding the impact of the condition on general function.  
 
Appendix 4.3: Extended discussion: Memory assessment 
 
Just over half (52%) of the participants were identified as having a ‘memory 
impairment’ on the AMIPB: Story Recall. This finding is consistent with the 
research that suggests that memory is one of the major impairments in 
schizophrenia (e.g. Gold et al., 1992; Landra et al., 1994; Rund, 1989; Saykin et 
al., 1991) and that this clinical population differs significantly from the ‘normal’ 
population on immediate and delayed verbal memory recall tasks (Wood et al., 
2006). Memory impairments have been reported to encompass a broad range of 
processes and so the AMIPB: Story Recall was a good measure to use because 
despite being verbally presented, it is thought to assess broad aspects of 
memory (e.g. retention and learning) and not specific memory system 
components (Coughlan & Hollows, 1985). 
 
Despite a significant proportion of the participants being identified as having a 
‘memory impairment’, there was a poor agreement with impairment on the 
CapQOL. This may be because the CapQOL was not sensitive to the memory 
skills that are assessed on the AMIPB: Story Recall subtest. A limitation of this 
 82 
study was that only one of the AMIPB tests (ie. Story Recall) were used. 
Coughlan and Hollows (1985) have suggested that their memory tests focus on 
differing aspects of memory. The reasons that only one test was administered 
were testing time constraints and that most of the sub-tests of the AMIPB 
correlate highly significantly with each other (Coughlan & Hollows, 1985). 
  
Future research may evaluate the associations between the CapQOL and the 
other sub-tests of the AMIPB (list learning, figure recall, design learning and 
number-cancellation tasks) and/or other memory assessment tools (e.g. 
Weschler Memory Scales (3rd ed.), Weschler, 1999; Rivermead Behavioural 
Memory Test (3rd ed), Wilson, Cockburn & Baddeley, 2007; Rey Complex Figure 
Test and Recognition Trial, Meyers & Meyers, 1995). 
 
Another limitation of the memory assessment component of this study is that 
autobiographical memory impairments were not assessed and compared with the 
CapQOL, despite the literature suggesting that they may contribute to the 
symptoms of schizophrenia (Baddeley et al., 1996: Feinstein et al., 1998; Riutort 
et al., 2003). Future research may therefore evaluate the associations between 
the CapQOL and a measure of autobiographical memory (e.g. the 
Autobiographical Memory Interview, Kopelman, Wilson & Baddeley, 1990), 
however, it is not known whether this is a specific deficit, due to a co-morbid 
depression or is part of a general long-term memory impairment in schizophrenia 
(Wood et al., 2006).  Therefore, another addition to a future research study that 
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includes a measure of autobiographical memory would be the assessment of 
depressive symptomatology using measures such as the Beck Depression 
Inventory-II (BDI-II) (Beck, Steer & Brown, 1996) and/ or the Hamilton 
Depression Inventory (HDI) (Williams, 1988).   
 
Appendix 4.4: Extended discussion: Executive functioning assessment  
 
The CapQOL demonstrated a poor agreement with executive functioning 
impairment/unimpairment. This finding would suggest that in its present form, the 
CapQOL does not detect executive functioning difficulties. However, the finding 
that many people with executive functioning impairments were able to ‘pass’ the 
CapQOL suggests that executive functioning skills may not be an essential 
requirement for completing QOL measures validly and reliably. 
 
There were variable overall levels of executive functioning impairments on the 
Hayling (61%) and Brixton (38%) Tests. These findings are consistent with most 
studies that suggest that people with schizophrenia show impaired ability on 
executive functioning tasks compared to normal healthy controls (e.g. Blanchard 
& Neal, 1994; Kinney et al., 1994) and that the magnitude of impairment is 
dependent on the measure used (Johnson-Selfridge & Zalewski, 2001). The 
Hayling Test detected more impaired participants than the Brixton Test. This may 
be because the Hayling Test purports to measure initiation speed and response 
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suppression whilst the Brixton Test measures rule detection (Wood & Liossi, 
2006).  
 
A criticism of executive functioning tests are that they probably involve several 
executive and non-executive processes (associated with brain areas outside the 
frontal lobes), and so no test can claim to be a ‘pure’ test of executive functioning 
(Wood & Liossi, 2006). Until such a test is developed (and that may never be the 
case), an improvement to this study would be to use a wider battery of executive 
functioning assessments (e.g. Behavioural Assessment of Dysexecutive 
Syndrome, Wilson et al., 1996; Wisconsin Card Sorting Test, Heaton, 1981; 
Controlled Word Association Test, Benton & Hamsher, 1976; Trail Making Test, 
Reitan & Wolfson, 1985) and assess their associations with the CapQOL. 
 
Appendix 4.5: Attention and vigilance observations: Implications for future 
research 
 
There were occasions during testing when some of the participant’s attention and 
vigilance on assessments appeared to be distracted. The distraction may have 
been a response to internal stimuli (e.g. auditory hallucinations), external stimuli 
(e.g. conversations outside the testing room) or ‘information overload’ (Seidman 
et al., 1998). This observation is consistent with research that has found that 
people with schizophrenia are significantly impaired to normal controls on 
attention and vigilance tasks (Seidman et al., 1998). People with schizophrenia 
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have often reported that these types of tasks involve ‘considerable effort’ 
(Seidman et al., 1998).  
 
Attention involves a series of processes that include focusing on a target, 
sustaining that focus and minimising distractibility to unimportant stimuli (i.e. 
vigilance), encoding stimulus properties and disengaging and shifting focus 
(Mirsky, Anthony, Duncan, Ahearn & Kellam, 1991). It has been proposed that 
people with schizophrenia have a deficit in information-processing resources that 
are required to undertake these higher processing demands and this results in 
‘information overload’ (Nuechterlein & Dawson, 1984). In order to assess the 
impact of attention and vigilance difficulties, a future study could use Continuous 
Performance Tests (CPT) (Seidman et al., 1998) in order to investigate if these 
types of difficulties are associated with impaired performance on the CapQOL 
and other cognitive assessments. 
 
Appendix 4.6: PANNS results and implications for future research 
 
The PANNS was chosen as a measure of positive and negative symptoms 
because of its psychometric properties (Kay, Fiszbein & Opler, 1987; Kay et al., 
1988; Kay et al. 2000) and so that comparisons could be made with the Wong et 
al. (2005) study. It was not possible to calculate positive and negative scores for 
10 of the participants. This was because those participants either became too 
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distressed during the PANNS interview or declined to take part in that section of 
the assessment due to the time that it took to complete (up to 60 minutes). 
 
The clinical observation of those people that did not complete the PANNS 
interview were that they generally displayed more overt symptomatology during 
testing. For example, some of the participants displayed significant levels of 
negative symptomatology, such as blunted affect, emotional withdrawal or poor 
rapport. Other participants displayed significant levels of positive 
symptomamotology in the form of suspiciousness, delusions and hallucinations. 
It seems likely that the participants where PANNS data was collected were less 
symptomatic than those that did not complete the PANNS interview. It is 
interesting to note that the mean PANNS scores for this sub sample were in a 
similar range to the early psychosis sample from the Wong et al. (2005) study, 
i.e. Wong et al. (2005) mean PANNS negative symptom score was 16 (s.d. = 7) 
compared to this study’s mean PANNS negative score of 19 (s.d. = 6). This 
would indicate that the lack of significant correlation with the CapQOL was not 
due to this study’s smaller distribution of negative symptom scores. 
 
On reflection, it would have been preferable to have used a more acceptable, 
shorter symptom rating scale with this sample. The Clinical Global Impression 
Scale – Schizophrenia (Haro et al., 2003) is a scale that may have been more 
appropriate. It takes less time to complete and has demonstrated good reliability 
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and validity when evaluating the severity of positive, negative, depressive and 
cognitive symptoms in schizophrenia populations (Mortimer, 2007). 
 
Appendix 4.7: Recruitment difficulties and declining rates 
 
62% of the people that were identified and approached about the study did not 
consent to take part. A review of 18 studies published between 2003 and 2007 
was undertaken to determine the research consent rates of schizophrenia 
populations. The main finding from this review was that very few studies reported 
the number of people that had not consented (despite the research being 
identified as ‘high quality’ by Cochrane reviews). Two studies did identify their 
rates of non-consenters to research. Durham, Guthrie, Morton, Reid & Treliving 
(2003) reported that in their study of CBT in a medication resistant schizophrenia 
sample, 44% did not consent to take part in their study. Greig, Zito, Wexler, 
Fizdon and Bell (2007) reported that in their study of the impact of cognitive 
training and vocational services on cognitive function, 48% did not consent to 
take part in their study. 
 
The consent rates for the Durham et al. (2003) and Greig et al. (2007) studies 
were higher than this study, however, the participants in the Greig et al. (2007) 
study had already been approached by clinicians and declared an initial interest 
in the study. This suggests that that consent rates would have been much lower 
than the 52% that they obtained. Making comparisons regarding consent rates is 
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difficult given that many of the research studies potential participants were 
‘referred’ to the study, suggesting that there was already some form of informal 
consent process undertaken by the referrer.  
 
There were significant difficulties in recruiting for this study. The original research 
sites were identified as two inpatient wards in Lincolnshire where the recruiter 
undertook the majority of his work. From these wards, only 6 out of the 18 people 
that were identified agreed to participate in the study. The number of beds (i.e. 
capacity) on the wards had also reduced since ethical approval had been sought; 
therefore the number of inpatient wards that were approached had to be 
increased.  
 
The observations of the recruiter recruiting at wards where he had limited 
involvement were that the patients on those wards were much more difficult to 
engage with and were more likely to be suspicious of his intentions. This 
appeared to have led to a higher ratio of people declining to take part in the 
study. This problem was also applicable to the nursing teams who were less 
facilitative in identifying participants and helping with the recruitment process. 
 
In order to improve recruitment levels for studies of this type, it appears to be 
important that potential participants know of and/or trust the recruiter. Of course, 
the strength of this relationship should never be exploited as a means to recruit 
people into a study. Recruitment may have been improved if recruiters were 
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based at specific sites, however the scarcity of Clinical Psychologists in 
Lincolnshire means that there is very limited input from Clinical Psychologists on 
some inpatient wards. 
 
It seems that the Wong et al. (2005) study had such a large sample size because 
the assessments were part of the admission procedure to the service. This would 
not be possible for chronic schizophrenia populations who are often long-term 
residents on inpatient wards or residential-homes. Nor would it be ethically 
acceptable for people to be denied admission to a ward if they declined to 
complete the assessments. 
 
This study was limited by the time available to collect participant data. Ethical 
approval (from COREC, Trust Research & Design and University Departments) 
was finally obtained in October 2006. The data had to be collected by August 
2007 in order that it could be analysed for submission in November 2007. This 
meant that there was a 10 month period where data could be collected. It 
appears that other schizophrenia research studies collect participant data over 
longer periods (e.g. several years). It seems likely that more time to collect data 
would have resulted in a larger sample size due to new patients being admitted 
to the inpatient wards and care home. 
  
Further delays in approaching participants occurred when contacting 
Responsible Medical Officers (RMO’s) regarding patient’s ability to consent (a 
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condition of COREC), arranging meetings with ward managers to discuss the 
research and agreeing suitable times to visit the inpatient wards and residential 
home. The tight deadline meant that only a limited amount of preparatory work 
could be done on the wards (i.e. meetings with ward mangers). Oral 
presentations about the research to the ward staff and patients may have 
improved consent rates, due to a greater awareness and appreciation of the 
study. 
 
The sample in this study turned out to be more heterogenous than had been 
anticipated, i.e. people were recruited from 6 inpatient wards and 1 residential 
home as opposed to the planned recruitment from 2 inpatient wards. Participants 
were under the care of differing RMOs, ward regimes and care teams. However, 
this sample appeared to be similar in many ways to the type of sample that are 
admitted to schizophrenia research units as described by Schreiber et al. (1990). 
For example, in both samples symptomatology is persistent and they have often 
had repeated hospitalisations. This study did not screen for ‘episodes of 
aggressive and flagrantly uncooperative behaviour’, a characteristic that often 
leads to exclusion from schizophrenia research units (Schreiber et al., 1990). 
Screening for these types of behaviour is undertaken because the units are 
looking for cooperative patient samples with whom a research and therapeutic 
alliance can be built (Schreiber et al., 1990). There are several known patients on 
Lincolnshire inpatient wards that demonstrate ‘aggressive and uncooperative 
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behaviours’, however when approached by the recruiter, they declined the 
opportunity to take part in the study, in effect excluding themselves.  
 
Clinical observations of the participants were that only a small minority would be 
described as acutely psychotic. The recruiter felt that those individuals that 
presented as paranoid or mistrustful would often decline the opportunity to take 
part in the study. These observations are consistent with Schreiber et al. (1990) 
suggestion that the acutely psychotic often decline treatment and research 
studies. The impact on this study (and other cognitive testing studies in 
schizophrenia populations) would be that the strength of associations between 
measures are reduced because of restricted score ranges on some measures.  
 
Appendix 4.8: Inter-rater reliability 
 
A limitation of this study is that the inter-rater reliability of the CapQOL was not 
assessed. Inter-rater reliability was beyond the scope (and resources) of this 
study. Another reason that this type of reliability was not assessed was that the 
CapQOL had already demonstrated good inter-rater reliability (0.92 for global 
scores) with the early psychosis sample (Wong et al., 2005). The danger of 
accepting that the CapQOL has good inter-rater reliability, based on the Wong et 
al. (2005) study is that the raters probably worked together on the development 
of the instrument. If this were the case, fairly consistent ratings would be 
expected, irrespective of the properties of the measure.  In clinical use, raters do 
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not have this level of knowledge, training or expertise regarding the tools that 
they use. Therefore, independent, inter-rater reliability studies of the CapQOL 
with early psychosis and chronic schizophrenia populations would be 
recommended. 
 
Appendix 4.9: Theoretical models 
 
A criticism of the CapQOL is that the authors did not propose any theoretical 
models to explain the processes involved in making a decision about subjective 
QOL. Experts in legal and bioethics generally agree that there are a least four 
components that are important for the capacity to make a decision: 
understanding information relevant to the decision; appreciating the information 
(applying the information to one’s own situation); using the information in 
reasoning; and expressing a consistent choice (Roth, Meisel & Lidz, 1977; Grisso 
& Appelbaum, 1998a).  
 
Decisional capacity for informed consent in schizophrenia research has been the 
focus of recent professional debate (Dunn, Nowrangi, Palmer, Jeste & Saks, 
2006). The four components of decisional capacity have been assessed in 
relation to informed consent using a structured instrument, the MacArthur 
Competence Assessment Tool (Mac-CAT) (Grisso & Appelbaum, 1998b). 
Carpenter et al. (2000) found that their schizophrenia sample did not perform as 
well as controls on an initial administration of the Mac-CAT. They found that poor 
performance was moderately related to symptomatology and strongly related to 
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cognitive impairment (Carpenter et al., 2000). However, when they applied a 
programme that consisted of two 30 minute educational sessions on the study 
described in the Mac-CT, provided prompts to ‘master’ the material and the 
option of using a computerised interactive programme, they found that the 
performance of their schizophrenia sample was equal to their control group 
(Carpenter et al., 2000). 
 
This finding has relevance to the CapQOL in that if people are educated and 
prompted in how to complete QOL measures, they may give more valid and 
reliable responses on the CapQOL and QOL measures. The CapQOL may be 
changed to include prompts to assist participants in completing the domains of its 
scales. Those prompts that were useful for a particular participant on the 
CapQOL could then be used when a QOL measure is administered. 
 
Appendix 4.10: Limitation: Estimate of pre-morbid IQ 
 
In order to partial out the effects of IQ on the memory and executive functioning 
assessments, the NART (Russell et al., 2000) was used as an estimate of pre-
morbid IQ. A limitation of this study is that only one measure of pre-morbid IQ 
was used. Russell et al. (2000) recommended that ideally, more than one 
measure of pre-morbid IQ should be used. A future study might only include 
adults with schizophrenia who had been assessed as children using the 
Weschler Intelligence Scales for Children (either WISC or WISC-R). The 
 94 
disadvantage of doing this in practice would be a large proportion of the adult 
schizophrenia population would be excluded. 
 
Another reason for using multiple sources to identify pre-morbid IQ is that Russell 
et al. (2000) suggested that NART scores that do not fall in the ‘average’ 
categories should be ‘interpreted with caution’. Three participants from this study 
were below the ‘average’ category range and so the accuracy that could have 
been attributed to their pre-morbid IQ estimates could have been enhanced with 
the collection of additional measurement data. 
 
Appendix 4.11: Limitation: Duration of illness 
 
The duration of illness was not measured despite Wong et al. (2005) suggesting 
that chronicity is associated with increased cognitive impairment. On the other-
hand, Johnson-Selfridge and Zalewski (2001) have demonstrated that duration of 
illness does not significantly affect executive functioning. The main reason for not 
considering duration of illness was the difficulty in assessing the onset of an 
‘illness’ such as schizophrenia from medical records that are incomplete and/or 
inconsistent in their descriptions of a patient’s onset and pre-morbid presentation. 
However, the duration of illness would appear to be more chronic in this study’s 
population when you consider their age range (25 - 64 years) and mean (43 
years), in comparison with the Wong et al. (2005) study (range = 18 – 29 years, 
mean = 22 years). 
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The number of hospitalisations has been related to executive functioning 
impairments (Johnson-Selfridge & Zalewski (2001), and may have been an 
easier factor to quantify. This factor would give an indication of duration and 
severity of illness (possibly because people with more symptoms require more 
hospitalisations). However, reviewing each participant’s medical notes (often with 
this population, multiple volumes) would be beyond the capacity of a project of 
this size. The accuracy and completeness of the records would also affect the 
validity and reliability of the data. 
 
Appendix 4.12: Limitation: diagnostic classification system 
 
The initial research proposal had stated that participants would be identified from 
DSM-IV diagnoses of Schizophrenia in their medical notes. The reality when 
reviewing participants’ medical notes was that the diagnostic classification 
system that was used was rarely cited or the Schizophrenia diagnosis was based 
on various versions (8-10) of the ICD classification system. In order to improve 
identification of participants’ diagnoses, future studies may request that the 
Responsible Medical Officer undertakes an up-to-date diagnostic classification 
based on an agreed classification system. Also, the diagnosis of schizophrenia 
and presence of persistent hallucinations and/or delusions could be confirmed 
using diagnostic checklists.  
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Appendix 4.13: Future study: Effect of medication 
 
All of the participants were being treated with anti-psychotic medications. This 
appears to be the ‘norm’ for inpatient and residential home chronic schizophrenic 
populations. Frith (1984) suggested that memory impairments are associated 
with the use of anticholinergic drugs and Benzodiazepines in the medical 
treatment of schizophrenia. Alternatively, memory improvements have been 
demonstrated in individuals that were prescribed the newer anti-psychotic 
medications such as Risperidone and Clozapine (Green et al., 1997; Keefe et al., 
1999). A future study could therefore evaluate the associations between 
medicated and unmedicated schizophrenic samples, CapQOL performance and 
cognitive testing performance. This study would identify if medication affects both 
cognitive testing and CapQOL performance, or cognitive tests but not CapQOL 
performance, or vice versa. The average chlorpromazine-equivalent neuroleptic 
daily dose could be calculated for the medicated groups in this proposed study, 
as described by Seidman et al. (1998). 
 
 Appendix 4.14: Face validity 
 
The authors of the CAPQOL claimed that it had face validity because it was 
developed from a review of the ‘most commonly used’ health related QOL 
measures and had questions that are depicted in QOL measures. 
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Correspondence with Dr Wong revealed that only three health-related QOL 
measures were reviewed (SF-36, QWB-SA, EORTC QLQ-C30). The CapQOL’s 
face validity may therefore be questionable given the extensive number of QOL 
measures that have been developed. 
 
Appendix 4.15: Proposed alterations to CapQOL terms and instructions 
 
On question 7, the term ‘economic status’ needed clarification by several 
participants. This term could be replaced with ‘wealth’ or ‘amount of money’ in 
order to ease comprehension. On question 9, several participants required 
clarification on the ‘type’ of relationship that was being asked about. For 
example, did the question mean a romantic, platonic or both ‘types’ of 
relationship? Either types of relationship that were described by participants were 
regarded as acceptable; however this was not specified in the instructions. The 
‘type’ of relationship could therefore be inserted in the question in order to lower 
confusion for participant and assessor. 
 
An administrative difficulty with the CapQOL was that it was rather unclear about 
the amount of ‘assistance and guidance’ that should be offered to participants 
that encounter difficulties. For example, a global score of 1 is assigned when the 
‘maximum assistance and guidance’ is provided to a participant. This is a very 
subjective description and clear instructions should be provided about what can 
and cannot be provided. Objective descriptions and instructions about the 
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amount of assistance and guidance that could be offered may have been given 
to the ‘trained’ assessors from the Wong et al. (2005) study.  
 
Appendix 4.16: Cut-off scores 
 
Consideration was given to whether the cut-off scores on the cognitive 
assessments were too lenient and if this then affected the sensitivity of the 
CapQOL. For example, was a 2 z-score cut-off for the AMIPB (in comparison to 
the NART) too lenient? Examination of the AMIPB raw scores indicted that those 
individuals that were identified as being impaired had very low raw scores that 
were in a similar range. This indicated that the cut-off scores were not too lenient. 
 
It was also considered if the cut-off score for impairment on the CapQOL were 
too stringent. For example, this study and the Wong et al. (2005) study classified 
‘impairment’ on the CapQOL as global scores ≤3. However, a score of 3 
indicated that the person ‘only has a fair understanding of QOL domains’ and 
‘may not have the ability and capacity’. Given that 43% (time 1) and 57% (time 2) 
of the participants were identified as unimpaired on the CapQOL, and the high 
rates of cognitive impairment, it would seem that the cut-off scores were not too 
stringent. 
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Appendix 4.17: Capacity to consent vs. capacity to appraise subjective 
QOL 
 
57% of the sample failed the CapQOL at time 1, indicating that they did not have 
the capacity to report their subjective QOL. However, the sample were all judged 
to have the capacity to make an informed decision (consent) regarding taking 
part in the study by four people: their Responsible Medical Officer (RMO), a 
member of their nursing team, the Clinical Psychologist (recruiter) responsible for 
their inpatient ward or care home and the chief investigator (test administrator).  
 
The consent process was designed so that people had sufficient information and 
understanding about the study in order to make an informed decision. The first 
stage involved the recruiter meeting the identified person and giving a verbal 
explanation of the study, a typed ‘layperson’ information sheet (agreed by Ethics 
committees) and the opportunity to ask questions. This initial meeting lasted from 
5 minutes to 60 minutes, dependent on the comprehension and/or interest of the 
identified person. If the identified person agreed to meet the chief investigator 
(test administrator), the second stage of the consent process involved them 
meeting (with a member of the nursing team present) 24 hours later. At this 
meeting, the identified person was asked about their understanding of the study 
and any misunderstandings were clarified. The person was again given the 
opportunity to ask questions. Having a second meeting meant that as well as a 
second opportunity to increase and assess understanding, the identified persons’ 
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ability to express consistent choices were sought (Roth et al., 1977; Grisso, 
1998a). 
 
This consent process gave information in different formats (i.e. verbal and 
written) by two different people, checked understanding and clarified information, 
and assessed consistency of responses (over a 24 hour period). This detailed 
and time consuming process is not part of the CapQOL administration procedure 
and may account for the number of participants that were identified as ‘impaired’ 
and lacking capacity on the CapQOL. 
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